Heart failure and antihypertensive medication

I9_HEARTFAIL_AND_ANTIHYPERT

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions RX_ANTIHYP	327810
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints I9_HEARTFAIL	48363
6. Filter based on genotype QC (FinnGen only)	42503

Control definitions (FinnGen only)

Control conditions: not RX_ANTIHYP

Extra metadata

First used in FinnGen datafreeze: DF5

NAME	I9_HEARTFAIL_AND_ANTIHYPERT
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!RX_ANTIHYP
SEX
INCLUDE	I9_HEARTFAIL
PRE_CONDITIONS
CONDITIONS	RX_ANTIHYP
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Heart failure and antihypertensive medication based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	392255	208935	178711
Only index persons	291613	157423	134190
Unadjusted period prevalence (%)
Whole population	5.52	5.98	4.99
Only index persons	5.48	5.79	5.12
Median age at first event (years)
Whole population	74.28	76.57	71.66
Only index persons	74.82	77.32	71.88

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	42503	17020	25483
Unadjusted period prevalence (%)	9.43	6.04	11.68
Median age at first event (years)	72.03	72.85	71.48

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
13090: Matched controls
84976

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C09AA01

ATC

captopril; oral

49.7

323.3

270

Single vessel balloon catheter extension

96.9

322.7

249

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

23.7

322.5

318

FL1AC

NOMESCO Finland

Left cardioangiography

24.1

320.7

315

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

13.7

318.4

389

189

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

14.4

318.2

380

176

TKC20

NOMESCO Finland

Catheterisation of bladder

3.9

317.9

1131

1992

N02AJ06

ATC

codeine and paracetamol; systemic

2.1

316.9

5314

21020

M10

ICD-10 Finland

Gout

5.9

315.9

700

807

N17.8

ICD-10 Finland

Other acute renal failure

18.0

315.8

343

127

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

70.7

309.1

246

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.8

308.5

1961

5016

N02AA05

ATC

oxycodone; systemic

2.5

308.0

2701

8135

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

54.5

307.7

842

107

ZXE00

NOMESCO Finland

One hour or less

2.3

307.7

5055

18484

SPAT1148

SPAT

Treatment of chronic ulcer or burn

4.7

307.7

2255

3606

TFP34

NOMESCO Finland

Electrophysiological investigation

19.7

307.7

675

234

A10BH01

ATC

sitagliptin; oral

9.0

307.7

1576

1270

J45.9

ICD-10 Finland

Asthma, unspecified

3.0

307.7

2631

6582

215

Kela drug reimbursment

Diabetes, non-insulin-treated

9.2

307.7

4532

4633

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

6.8

307.7

2374

2673

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

6.4

307.7

2072

2442

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

41.0

307.7

1691

306

B01AF01

ATC

rivaroxaban; oral

3.7

307.7

1860

3665

A02BC02

ATC

pantoprazole; systemic

2.6

307.7

9126

39521

C09CA07

ATC

telmisartan; oral

28.1

307.7

702

171

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.4

307.7

1491

3137

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

10.1

307.7

923

632

C08CA13

ATC

lercanidipine; oral

145.1

307.7

2008

106

205

Kela drug reimbursment

Chronic hypertension

48.5

307.7

4673

962

WX722

NOMESCO Finland

PEEP

7.2

307.7

910

877

I20.00

ICD-10 Finland

Unstable angina

20.9

307.7

448

144

SPAT1097

SPAT

Recording of ECG

3.8

307.7

1891

3588

A12AA04

ATC

calcium carbonate; oral

45.3

307.7

426

I49.5

ICD-10 Finland

Sick sinus syndrome

14.9

307.7

650

296

Z94.0

ICD-10 Finland

Kidney transplant status

187.7

307.7

338

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

307.7

793

M10.0

ICD-10 Finland

Idiopathic gout

9.6

307.7

620

440

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

24.2

307.7

2067

654

I20.99

ICD-10 Finland

Angina pectoris, unspecified

13.6

307.7

1147

595

B01AC06

ATC

acetylsalicylic acid; oral

25.7

307.7

414

108

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

38.7

307.7

2239

451

AP1

Catheterization of the left side of the heart

56.6

307.7

315

C07BB07

ATC

bisoprolol and thiazides; systemic

460.7

307.7

413

C09DB01

ATC

valsartan and amlodipine; oral

51.2

307.7

278

R03BB04

ATC

tiotropium bromide; inhalant

4.3

307.7

1867

3169

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

108.9

307.7

744

I25.1

ICD-10 Finland

Atherosclerotic heart disease

19.4

307.7

5111

2714

R04.0

ICD-10 Finland

Epistaxis

4.8

307.7

1162

1696

C09BA02

ATC

enalapril and diuretics; systemic

317.3

307.7

1118

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

22.0

307.7

1936

666

C07AB05

ATC

betaxolol; oral

51.3

307.7

271

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

48.2

307.7

4456

901

SPAT1249

SPAT

Treatment-related counselling outside office

2.2

307.7

4416

16110

AN1

Coronary angiography

35.1

307.7

2649

609

N02BE01

ATC

paracetamol; systemic, rectal

3.1

307.7

11394

58400

OAB50, ,

SPAT

4.3

307.7

1125

1817

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

51.6

307.7

1006

137

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

23.3

307.7

467

135

B03XA02

ATC

darbepoetin alfa; parenteral

11.3

307.7

545

326

L04AA06

ATC

mycophenolic acid; systemic

21.1

307.7

604

194

C09AA03

ATC

lisinopril; oral

78.0

307.7

497

R02

ICPC

Shortness of breath/dyspnoea

5.7

307.7

2652

3647

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

30.4

307.7

2168

551

K84

ICPC

Heart disease other

26.7

307.7

624

159

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.6

307.7

2663

7525

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

4.8

307.7

1516

2271

K86

ICPC

Hypertension uncomplicated

18.8

307.7

1236

469

B01AA03

ATC

warfarin; systemic

16.6

307.7

5089

3142

A10AB01

ATC

insulin (human); parenteral

8.2

307.7

574

471

Z49.1

ICD-10 Finland

Extracorporeal dialysis

86.4

307.7

475

N17.9

ICD-10 Finland

Acute renal failure, unspecified

16.7

307.7

1246

532

207

Kela drug reimbursment

Chronic arrhythmias

100.0

307.7

4685

471

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

16.8

307.7

999

415

C09DA01

ATC

losartan and diuretics; oral

158.0

307.7

1114

H02AB06

ATC

prednisolone; systemic

2.7

307.7

6758

24389

K78

ICPC

Atrial fibrillation/flutter

28.9

307.7

1795

465

XF404

NOMESCO Finland

Ambulatory ECG

12.7

307.7

1942

1152

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.5

307.7

3045

9301

ZXD05

NOMESCO Finland

Urgent procedure

3.7

307.7

4781

11401

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

104.5

307.7

872

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

5.5

307.7

1183

1517

A11CC03

ATC

alfacalcidol; systemic

30.4

307.7

676

152

TK800

NOMESCO Finland

Hemodialysis

37.2

307.7

787

146

K80

ICPC

Cardiac arrhythmia NOS

4.4

307.7

1000

1554

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

41.6

307.7

374

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

8.6

307.7

573

448

R4110

NOMESCO Finland

Physiotherapy

2.6

307.7

4114

12836

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

74.4

307.7

335

B01AF02

ATC

apixaban; oral

14.6

307.7

3232

1871

ZX120

NOMESCO Finland

Intravenous

3.5

307.7

1652

3399

I50.1

ICD-10 Finland

Left ventricular failure

152.3

307.7

3921

238

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

14.6

307.7

515

237

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

33.3

307.7

461

I20.90

ICD-10 Finland

Angina pectoris, unspecified

15.1

307.7

537

240

V03AE01

ATC

polystyrene sulfonate; oral

31.8

307.7

376

TFP35

NOMESCO Finland

Electroanatomical mapping

31.0

307.7

303

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

56.7

307.7

711

K77

ICPC

Heart failure

130.5

307.7

864

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

13.7

307.7

450

220

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

19.6

307.7

341

116

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

29.7

307.7

1775

446

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

10.4

307.7

4695

4341

C09DA03

ATC

valsartan and diuretics; oral

255.6

307.7

456

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

7.3

307.7

1518

1505

TPH07

NOMESCO Finland

Cathetrisation of artery

5.7

307.7

2387

3182

C01BD01

ATC

amiodarone; systemic

306.0

307.7

1238

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

72.1

307.7

891

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

21.9

307.7

1897

652

JN3AD

NOMESCO Finland

Abdominal CT examination

2.9

307.7

1994

4899

C09DA06

ATC

candesartan and diuretics; oral

141.3

307.7

759

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

84.7

307.7

716

Z49.0

ICD-10 Finland

Preparatory care for dialysis

162.1

307.7

293

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.5

307.7

2668

5785

A10BK01

ATC

dapagliflozin; oral

20.3

307.7

2265

865

A10BA02

ATC

metformin; oral

7.8

307.7

4818

5876

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

8.2

307.7

3063

3037

AN3

Balloon angioplasty and metallic stent

38.6

307.7

364

B01AE07

ATC

dabigatran etexilate; oral

8.8

307.7

580

447

B01AC24

ATC

ticagrelor; oral

39.8

307.7

620

106

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

5.1

307.7

918

1245

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

5.0

307.7

1379

1946

C07AB12

ATC

nebivolol; oral

41.4

307.7

299

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.4

307.7

1574

3267

C07AB02

ATC

metoprolol; systemic

26.2

307.7

3262

1064

E66.8

ICD-10 Finland

Other obesity

8.9

307.7

943

733

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

98.1

307.7

252

T90

ICPC

Diabetes non-insulin dependent

7.8

307.7

4230

4876

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.8

307.7

4297

12610

K85

ICPC

Elevated blood pressure

5.9

307.7

1617

1977

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

29.2

307.7

1023

246

C09AA04

ATC

perindopril; oral

56.4

307.7

707

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

11.2

307.7

1939

1304

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.2

307.7

4642

16760

C09CA01

ATC

losartan; oral

34.8

307.7

3561

903

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

7.9

307.7

808

704

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

36.0

307.7

430

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

16.6

307.7

498

202

A28

ICPC

Limited function/disability NOS

4.2

307.7

2947

5522

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

99.4

307.7

314

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

221.1

307.7

332

201

Kela drug reimbursment

Chronic cardiac insufficiency

55.1

307.7

3794

625

S97

ICPC

Chronic ulcer skin

8.3

307.7

1459

1258

Z3231

NOMESCO Finland

Registered nurse

2.6

307.7

3810

11476

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

32.5

307.7

6465

2475

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

16.0

307.7

523

220

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

19.7

307.7

1134

407

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

13.6

307.7

1029

530

C10AA01

ATC

simvastatin; oral

5.2

307.7

6171

12489

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

35.9

307.7

1454

295

A10BH05

ATC

linagliptin; oral

15.9

307.7

939

412

A10BJ05

ATC

dulaglutide; parenteral

24.6

307.7

329

I20.09

ICD-10 Finland

Unstable angina

17.0

307.7

946

387

C02EA02, ,

ATC

28.6

307.7

565

134

SPAT1254

SPAT

Administration of medicine

3.8

307.7

2066

3987

A10BJ06

ATC

semaglutide; parenteral

17.2

307.7

978

396

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

4.7

307.7

1525

2325

I10

ICD-10 Finland

Essential (primary) hypertension

44.2

307.7

9350

4549

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

52.9

307.7

403

C08DA01

ATC

verapamil; systemic

21.1

307.7

594

191

J01MA12

ATC

levofloxacin; systemic

2.8

307.7

2874

7762

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.6

307.7

2328

3779

C09DA07

ATC

telmisartan and diuretics; oral

125.2

307.7

393

C08DB01

ATC

diltiazem; oral

49.5

307.7

803

112

137

Kela drug reimbursment

Uraemia requiring dialysis

158.4

307.7

263

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

42.6

307.7

619

R53

ICD-10 Finland

Malaise and fatigue

2.4

307.7

3059

9538

C03DA01

ATC

spironolactone; oral

46.5

307.7

5353

1245

I48.2

ICD-10 Finland

Chronic atrial fibrillation

112.7

307.7

1562

102

C09AA05

ATC

ramipril; oral

91.0

307.7

6148

819

C08CA05

ATC

nifedipine; systemic

11.1

307.7

781

484

R03AC02

ATC

salbutamol; inhalant

2.2

307.7

6876

28182

C09AA02

ATC

enalapril; systemic

66.6

307.7

3164

405

Angiography of the heart and coronary arteries

35.2

307.7

1073

215

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

16.1

307.7

626

264

A10AB05

ATC

insulin aspart; parenteral

10.7

307.7

1624

1107

E11

ICD-10 Finland

Type 2 diabetes mellitus

6.5

307.7

2405

2857

C07AB07

ATC

bisoprolol; oral

79.7

307.7

10688

4493

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

20.6

307.7

1235

428

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

307.7

895

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

15.7

307.7

5161

3379

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

4.1

307.7

2050

3673

C07AG02

ATC

carvedilol; oral

95.3

307.7

1091

I42.0

ICD-10 Finland

Dilated cardiomyopathy

234.7

307.7

1915

I47.2

ICD-10 Finland

Ventricular tachycardia

63.7

307.7

733

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

27.8

307.7

3737

1206

A10AC01

ATC

insulin (human); parenteral

10.1

307.7

1465

1046

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

17.5

307.7

518

200

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

41.3

307.7

532

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

15.5

307.7

736

325

A10BK03

ATC

empagliflozin; oral

15.8

307.7

2471

1233

XF402

NOMESCO Finland

ECG with work load test

6.3

307.7

1665

1924

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

4.0

307.7

2445

4665

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

15.2

307.7

2422

1253

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

9.3

307.7

4650

4743

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

53.5

307.7

598

250, ,

Kela drug reimbursment

596.1

307.7

1395

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

7.7

307.7

730

643

E66.01

ICD-10 Finland

Obesity due to excess calories

7.3

307.7

1558

1541

XCK10

NOMESCO Finland

Photography of fundus of eye

4.1

307.7

1372

2333

XF600

NOMESCO Finland

Bloodpressure measurement

4.8

307.7

1019

1465

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.3

307.7

2063

4584

WX872

NOMESCO Finland

Intensive care

13.4

307.7

1332

712

A46

ICD-10 Finland

Erysipelas

4.8

307.7

2969

4931

A41.9

ICD-10 Finland

Sepsis, unspecified

5.8

307.7

745

875

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

34.1

307.7

1305

275

N19

ICD-10 Finland

Unspecified kidney failure

18.9

307.7

822

300

C03AA03

ATC

hydrochlorothiazide; oral

22.5

307.7

1330

425

M04AA01

ATC

allopurinol; systemic

8.9

307.7

2863

2598

TPH04

NOMESCO Finland

Cathetrisation of vein

3.7

307.7

3821

8480

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

53.8

307.7

1074

141

I48.1

ICD-10 Finland

Persistent atrial fibrillation

66.6

307.7

1413

154

WX892

NOMESCO Finland

Monitored bed care

7.5

307.7

1735

1702

I35.0

ICD-10 Finland

Aortic (valve) stenosis

11.7

307.7

1182

716

I48

ICD-10 Finland

Atrial fibrillation and flutter

31.2

307.7

5900

2180

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.0

307.7

5142

11712

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

133.8

307.7

419

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

22.5

307.7

361

107

A10BB12

ATC

glimepiride; oral

11.8

307.7

1142

683

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.2

307.7

2106

3710

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

10.9

307.7

499

307

XF640, ,

NOMESCO Finland

13.5

307.7

528

264

AN4

Balloon angioplasty and drug eluding stent

44.0

307.7

502

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

14.7

307.7

397

181

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

91.0

307.7

716

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

6.0

307.7

753

859

C10AA05

ATC

atorvastatin; oral

4.7

307.7

6559

14970

I50.0

ICD-10 Finland

Congestive heart failure

96.4

307.7

4484

457

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

77.8

307.7

1038

C02AC05

ATC

moxonidine; oral

600.4

307.7

864

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

27.9

307.7

449

108

XF400

NOMESCO Finland

ECG with 12 standard connections

5.3

307.7

2982

4499

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

6.6

307.7

3974

5259

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

5.8

307.7

1062

1266

127

Kela drug reimbursment

Transplant complication

38.4

307.7

540

R06.0

ICD-10 Finland

Dyspnoea

6.4

307.7

5663

9040

K07

ICPC

Swollen ankles/oedema

7.3

307.7

794

742

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

6.3

307.7

1779

2071

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

7.3

307.7

775

731

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

14.1

307.7

588

283

I25.2

ICD-10 Finland

Old myocardial infarction

45.3

307.7

1637

267

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

18.4

307.7

426

155

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

8.2

307.7

808

677

GD1AA

NOMESCO Finland

Thorax X-ray examination

7.1

307.7

9090

20684

ZXE20

NOMESCO Finland

More than three and less than five hours

3.4

307.7

2070

4474

E87.6

ICD-10 Finland

Hypokalaemia

8.3

307.7

589

480

A10BJ02

ATC

liraglutide; parenteral

24.2

307.7

519

145

160

Kela drug reimbursment

exenatide

54.8

307.7

409

D64.9

ICD-10 Finland

Anaemia, unspecified

5.1

307.7

2055

3012

B01AB05

ATC

enoxaparin; parenteral

2.7

307.7

4609

14075

I20.01

ICD-10 Finland

Unstable angina

44.5

307.7

476

GD1LA

NOMESCO Finland

39.8

307.7

507

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

53.8

307.7

1401

189

M10.9

ICD-10 Finland

Gout, unspecified

10.0

307.7

1471

1064

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

38.4

307.7

385

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.4

307.7

2009

4299

E87.5

ICD-10 Finland

Hyperkalaemia

23.5

307.7

496

142

G47.3

ICD-10 Finland

Sleep apnoea

3.3

307.7

3466

8446

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.9

307.7

2176

5457

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

22.9

307.7

1217

379

103

Kela drug reimbursment

Diabetes, insulin-treated

8.8

307.7

5114

5797

C08CA02

ATC

felodipine; oral

83.4

307.7

1402

122

C01DA14

ATC

isosorbide mononitrate; oral

20.3

307.7

3007

1233

K99

ICPC

Cardiovascular disease other

10.2

307.7

468

307

H25.1

ICD-10 Finland

Senile nuclear cataract

2.3

307.7

3362

10901

N02AX02

ATC

tramadol; systemic, rectal

2.4

307.7

5999

22343

K87

ICPC

Hypertension complicated

53.4

307.7

321

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.4

307.7

1604

3372

C07AA07

ATC

sotalol; systemic

42.7

307.7

681

109

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

57.5

307.7

689

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

25.5

307.7

1324

374

R5140

NOMESCO Finland

Monitoring the use of the aid

3.6

307.7

1720

3383

J01DB01

ATC

cefalexin; oral

2.5

307.7

10451

52146

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

11.8

307.7

4769

3924

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

133.9

307.7

867

C08CA01

ATC

amlodipine; oral

56.5

307.7

5937

1230

SPAT1301

SPAT

No procedures

2.3

307.7

3703

12385

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

154.4

307.7

1422

N18.8

ICD-10 Finland

Other chronic renal failure

52.5

307.7

646

J96.1

ICD-10 Finland

Chronic respiratory failure

9.6

307.7

631

445

L28

ICPC

Limited function/disability (L)

3.4

307.7

2862

6390

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

7.4

307.7

1079

1021

N18.0

ICD-10 Finland

End-stage renal disease

70.2

307.7

296

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.1

307.7

1872

4351

J01FF01

ATC

clindamycin; systemic

2.6

307.7

3960

12168

XFE00

NOMESCO Finland

Epicardial ultrasonography

12.9

307.7

441

229

C07AB03

ATC

atenolol; systemic

34.0

307.7

836

170

E66.00

ICD-10 Finland

Metabolic syndrome

13.6

307.7

1098

568

A10AE05

ATC

insulin detemir; parenteral

11.7

307.7

1020

608

C09CA06

ATC

candesartan; oral

15.4

307.7

2697

1407

I44.2

ICD-10 Finland

Atrioventricular block, complete

16.3

307.7

628

262

I25

ICD-10 Finland

Chronic ischaemic heart disease

29.8

307.7

622

142

C09DX04

ATC

valsartan and sacubitril; oral

+∞

307.7

850

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

159.4

307.7

335

N05CF01

ATC

zopiclone; oral

2.2

307.7

4220

14942

L04AD02

ATC

tacrolimus; systemic

50.2

307.7

383

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

2.6

307.7

4120

12889

K76

ICPC

Ischaemic heart dis without angina

28.0

307.7

308

C03CA01

ATC

furosemide; systemic

55.1

307.7

10553

5965

C09CA03

ATC

valsartan; oral

65.0

307.7

1398

156

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

3.2

307.7

3846

9777

TFP20

NOMESCO Finland

Cardiodefibrillation

60.6

307.7

2218

285

I50

ICD-10 Finland

Heart failure

101.0

307.7

1151

R60.0

ICD-10 Finland

Localized oedema

4.3

307.7

2115

3671

C01AA05

ATC

digoxin; systemic

23.2

307.7

2696

941

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.4

307.7

1912

4071

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

20.9

307.7

536

173

SPAT1262

SPAT

Handing over of treatment supplies

5.4

307.7

2807

4066

A12BA01

ATC

potassium chloride; oral

27.2

307.7

860

219

AA1AD

NOMESCO Finland

CT of head and brain

3.8

307.7

4618

10604

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

30.1

307.7

556

125

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

62.9

307.7

548

AA1

Conventional CABG

163.8

307.7

320

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

7.4

307.7

1218

1163

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

101.1

307.7

859

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

5.5

307.7

1172

1487

C01BC04

ATC

flecainide; systemic

37.7

307.7

449

SPAT1263

SPAT

Sampling

2.4

307.7

4972

17520

A08

ICPC

Swelling

6.3

307.7

1047

1160

A10AE04

ATC

insulin glargine; parenteral

12.0

307.7

2027

1283

ZXE10

NOMESCO Finland

More than one and less than three hours

2.2

307.7

4637

17169

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

16.0

307.7

6433

4844

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

26.0

307.7

1097

298

E66.9

ICD-10 Finland

Obesity, unspecified

9.0

307.7

575

431

I50.9

ICD-10 Finland

Heart failure, unspecified

205.3

307.7

9717

1176

C10AA04

ATC

fluvastatin; oral

4.6

307.7

973

1463

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

42.3

307.7

580

R07.4

ICD-10 Finland

Chest pain, unspecified

3.1

307.7

3912

10145

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

67.2

307.7

715

B01AC04

ATC

clopidogrel; oral

11.3

307.7

2989

2177

C10AX09

ATC

ezetimibe; oral

5.4

307.7

2582

3707

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

10.3

307.7

2043

1505

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

5.1

307.7

3764

6282

Coronary artery bypass surgery

77.9

307.7

305

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

44.1

307.7

4018

845

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

307.6

3440

11551

Z3226

NOMESCO Finland

Physiotherapist

2.5

307.4

2449

7043

H3601, E113,

ICD-10 Finland

32.3

306.4

278

C07AB08

ATC

celiprolol; oral

49.6

305.4

255

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

87.0

304.2

237

C03BA11

ATC

indapamide; oral

27.3

304.1

288

C10AA03

ATC

pravastatin; oral

4.6

303.4

871

1287

I49.3

ICD-10 Finland

Ventricular premature depolarization

4.7

303.3

865

1271

XG466

NOMESCO Finland

Sleep oxymetry

6.6

303.1

606

623

I42.8

ICD-10 Finland

Other cardiomyopathies

91.4

303.0

235

TK810

NOMESCO Finland

Hemofiltration

53.4

302.8

250

I34.1

ICD-10 Finland

Mitral (valve) prolapse

8.5

302.7

494

392

A10AB04

ATC

insulin lispro; parenteral

8.4

302.6

496

396

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

96.2

301.8

233

R55

ICD-10 Finland

Syncope and collapse

3.2

300.4

1517

3391

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

32.6

299.4

271

K29

ICPC

Cardiovascular sympt/complt other

6.0

299.1

646

724

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

6.6

297.4

590

601

S18

ICPC

Laceration/cut

2.0

296.6

5956

24995

A10AA02, ,

ATC

7.0

295.5

559

538

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.1

294.9

4212

15573

SPAT1229

SPAT

Assessment of need for aid

3.8

294.8

1091

1976

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

+∞

294.6

335

R60.9

ICD-10 Finland

Oedema, unspecified

4.5

294.5

876

1334

B01AF03

ATC

edoxaban; oral

13.9

294.1

357

171

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

386.0

294.1

348

PD5AD

NOMESCO Finland

CT of aorta

9.3

293.7

448

322

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

9.0

290.8

453

336

SPAT1100

SPAT

Long-term monitoring of blood pressure

5.1

290.4

748

1001

SPAT1255

SPAT

Intravenous administration of medicine

4.0

290.3

1018

1770

GD1AD

NOMESCO Finland

Thorax CT examination

3.7

290.1

1128

2117

Z2221

NOMESCO Finland

Medical doctor

2.2

289.5

3376

11494

I48.3

ICD-10 Finland

Typical atrial flutter

25.5

287.0

277

T89

ICPC

Diabetes insulin dependent

6.3

286.8

596

640

NHQ40

NOMESCO Finland

Amputation of toe

12.6

286.3

365

193

H3603, E103,

ICD-10 Finland

37.0

286.2

252

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

24.1

285.4

280

SPAT1216

SPAT

Assessment of functional ability

2.7

285.0

1884

4909

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

4.1

284.9

943

1567

R50.9

ICD-10 Finland

Fever, unspecified

2.6

283.1

2160

6059

A06AD11

ATC

lactulose; oral

2.6

282.9

2115

5872

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

14.0

282.4

342

163

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

26.6

282.1

269

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

33.3

279.8

252

JN4AD

NOMESCO Finland

Body CT examination

2.7

279.6

1850

4819

A10BX07

ATC

[U] liraglutide

52.6

279.2

231

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

4.0

278.2

951

1620

SPAT1310

SPAT

Counselling related to known health issue

2.2

277.2

3421

11888

A10AE06

ATC

insulin degludec; parenteral

7.3

277.2

508

470

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.5

276.6

1155

2277

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

273.6

275.1

330

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

21.0

275.0

282

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

18.4

273.3

294

106

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

5.7

273.3

619

729

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.4

271.1

2563

7942

E86

ICD-10 Finland

Volume depletion

7.9

270.0

462

391

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

5.8

268.2

602

702

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

4.5

268.1

799

1217

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

351.7

267.8

318

A10BB01

ATC

glibenclamide; oral

6.0

265.6

574

643

ZXD10

NOMESCO Finland

Scheduled procedure

2.0

265.3

4703

18679

N03AX16

ATC

[U] pregabalin

2.3

265.0

2834

9258

C02DE04, ,

ATC

25.0

264.9

257

UJF32

NOMESCO Finland

Coloscopy

2.1

264.0

3361

11791

Catheterization and pressure measurement of the left side of the heart

33.2

261.7

236

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

27.2

260.8

247

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

25.0

260.7

253

A04

ICPC

Weakness/tiredness general

2.7

260.2

1829

4906

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

30.4

259.6

239

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

7.6

258.8

457

403

J96.0

ICD-10 Finland

Acute respiratory failure

11.9

258.4

339

189

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

26.3

258.4

247

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

257.8

5065

20801

SPAT1252

SPAT

Overall medication plan or its review

4.2

257.3

831

1352

A10AD05

ATC

insulin aspart; parenteral

17.0

255.8

284

111

K83

ICPC

Heart valve disease NOS

29.4

254.3

236

Z50.0

ICD-10 Finland

Cardiac rehabilitation

87.0

254.1

198

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.9

253.7

1479

3583

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

8.4

252.7

412

326

I47.1

ICD-10 Finland

Supraventricular tachycardia

6.3

251.5

518

550

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

9.1

250.5

388

285

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

26.0

250.2

240

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

15.9

249.3

284

118

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

5.0

247.1

643

867

H36.01

ICD-10 Finland

Diabetic maculopathy

21.6

247.0

251

AN2

Balloon angioplasty, including several vessels

9.4

246.7

374

266

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.5

246.0

1958

5578

N05BA04

ATC

oxazepam; oral

2.2

245.9

3019

10398

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

40.1

245.9

213

L17

ICPC

Foot/toe symptom/complaint

2.0

245.7

3658

13565

EBA15

NOMESCO Finland

Extraction of multiple teeth

4.4

245.2

752

1172

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

40.9

244.5

211

162

Kela drug reimbursment

liraglutide

46.8

244.4

206

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.2

244.2

787

1277

J01MA02

ATC

ciprofloxacin; systemic

1.9

244.2

4889

20111

TQW11

NOMESCO Finland

Vacuum treatment of wound

7.5

244.1

436

390

C07FB02

ATC

metoprolol and felodipine; systemic

475.5

244.0

287

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

243.8

5342

22642

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

4.2

243.7

777

1250

A10BD07

ATC

metformin and sitagliptin; systemic

6.3

243.3

503

536

C07AA05

ATC

propranolol; systemic

2.8

242.6

1545

3926

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

34.1

242.2

217

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

5.4

241.8

580

723

Z2446

NOMESCO Finland

Social worker

3.7

241.0

936

1749

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.7

239.7

1598

4159

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

6.7

238.8

468

469

R00.1

ICD-10 Finland

Bradycardia, unspecified

6.5

238.8

478

491

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

66.2

238.1

191

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.4

236.9

2175

6614

H3600, E113,

ICD-10 Finland

29.4

234.8

218

WX882

NOMESCO Finland

High dependency care

5.9

234.0

511

578

K28

ICPC

Limited function/disability (K)

9.1

233.7

361

264

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

6.1

233.5

497

547

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

4.8

232.0

633

891

J01MA14

ATC

moxifloxacin; systemic

2.9

231.3

1332

3197

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.3

230.2

1047

2177

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.5

229.5

933

1799

A10AA01, ,

ATC

7.4

229.4

414

375

SPAT1104

SPAT

Monitoring of emergency patient

3.8

229.4

833

1481

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

23.1

228.4

227

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

28.2

228.2

214

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

3.7

228.0

882

1642

A10BG03

ATC

pioglitazone; oral

10.6

227.0

318

199

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.9

226.8

1320

3186

T82

ICPC

Obesity

5.8

226.7

504

581

K92.1

ICD-10 Finland

Melaena

4.0

226.3

785

1348

R42

ICD-10 Finland

Dizziness and giddiness

2.2

225.4

2601

8701

H3603, E113,

ICD-10 Finland

44.9

225.1

191

177

Kela drug reimbursment

Insulin glargine 300 U / ml

12.4

224.8

289

155

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

9.5

223.9

336

235

SPAT1325

SPAT

Vaccination

2.0

223.9

3472

12993

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

37.1

223.9

197

N06AX11

ATC

mirtazapine; oral

1.9

223.9

3879

15094

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

14.7

223.6

264

119

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

251.6

221.6

267

SPAT1260

SPAT

Consultation of another employee

2.4

219.7

1975

5933

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

32.0

218.9

199

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

4.5

218.7

647

977

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

7.5

218.6

390

348

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

217.9

2783

9676

PE1AT

NOMESCO Finland

Femoral artery PTA

22.2

217.8

219

FPE37

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

217.8

248

PD5BD

NOMESCO Finland

Extensive CT of aorta

12.7

217.8

276

144

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

1604.3

216.3

249

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

18.1

215.5

233

4019X

ICD-9 Finland

Essential hypertension, Unspecified

8.8

215.3

339

255

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.5

213.1

1607

4439

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

241.9

212.9

257

3AC01, ,

NOMESCO Finland

17.1

212.3

235

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

83.9

212.3

166

I44.1

ICD-10 Finland

Atrioventricular block, second degree

9.1

211.8

326

237

A10BH02

ATC

vildagliptin; oral

13.5

209.2

257

126

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

5.0

209.0

538

717

C10AA07

ATC

rosuvastatin; oral

1.9

208.7

3677

14326

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

274.7

208.3

250

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

6.6

208.1

410

413

A10BX04

ATC

[U] exenatide

51.4

207.2

172

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.0

206.4

3156

11699

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

3.3

206.0

938

1948

N03AX12

ATC

[U] gabapentin; oral

2.4

205.9

1834

5474

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

26.0

205.4

197

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

16.9

205.3

228

R11

ICD-10 Finland

Nausea and vomiting

3.0

203.7

1082

2471

N05CD07

ATC

temazepam; oral

2.5

203.7

1608

4536

WZC30

NOMESCO Finland

Teaching

2.2

203.7

2231

7277

KA1AE

NOMESCO Finland

Kidney ultrasound examination

6.2

202.5

421

451

H36.00

ICD-10 Finland

Diabetic background retinopathy

14.2

201.2

241

112

A02BC01

ATC

omeprazole; systemic

2.0

200.7

3148

11757

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.6

199.4

794

1506

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

23.2

198.6

197

SPAT1211

SPAT

Application of soft bandage

3.0

198.3

1081

2506

R5110, ,

SPAT

2.9

197.8

1125

2672

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

84.3

197.0

154

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

23.7

196.8

194

C08CA10

ATC

nilvadipine; oral

756.1

196.7

229

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.8

196.5

1197

2954

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

5.5

196.1

458

555

AS4

Physiological pacemaker insertion DDD (R)

19.8

195.1

204

Z49.2

ICD-10 Finland

Other dialysis

503.7

194.9

229

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

4.1

194.9

651

1084

OAB43, ,

SPAT

0.4

194.7

991

15292

N05BA01

ATC

diazepam; systemic, rectal

2.4

194.7

1579

4506

SPAT1081

SPAT

Cardiorespiratory global assessment

4.6

194.5

549

795

1CX08, ,

NOMESCO Finland

377.5

193.2

229

S76

ICPC

Skin infection other

3.5

192.7

797

1551

C09BA03

ATC

lisinopril and diuretics; oral

497.0

192.3

226

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

34.3

192.2

172

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

194.2

191.5

234

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.3

191.0

586

911

J01DA01

ATC

[U] cefalexin

1.7

190.8

7390

36264

WX002

NOMESCO Finland

Sedation and analgesia

2.1

190.6

2327

7905

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.0

190.6

1013

2312

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

22.7

190.4

190

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

88.3

190.2

148

B05DA

ATC

Isotonic solutions

490.3

189.7

223

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

5.7

189.5

428

501

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

10.4

187.6

265

168

H05BX01

ATC

cinacalcet; oral

40.7

186.4

161

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

48.5

185.0

155

H02AB04

ATC

methylprednisolone; systemic

2.3

184.7

1822

5669

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

15.5

184.3

212

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.8

183.6

4598

19850

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.3

182.0

816

1675

K08.3

ICD-10 Finland

Retained dental root

2.8

181.8

1120

2777

Z02.7

ICD-10 Finland

Issue of medical certificate

3.0

181.0

958

2179

I20.91

ICD-10 Finland

Angina pectoris, unspecified

45.4

179.4

152

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

9.1

179.1

275

199

WX725

NOMESCO Finland

Noninvasive ventilation

3.2

178.8

828

1735

ZXA00

NOMESCO Finland

Right side

1.9

178.6

3164

12245

N05AH04

ATC

quetiapine; oral

2.2

178.5

1919

6183

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

27.1

178.3

169

J01CF05

ATC

flucloxacillin; systemic

3.0

177.9

929

2096

E66.0

ICD-10 Finland

Obesity due to excess calories

18.2

177.3

191

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

4.8

177.2

479

667

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

27.4

176.8

167

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

345.5

176.6

210

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

16.3

175.8

198

B05DB

ATC

Hypertonic solutions

454.4

175.7

207

R31

ICD-10 Finland

Unspecified haematuria

2.5

173.3

1293

3535

SPAT1251

SPAT

Organisation of medication

5.1

173.2

441

581

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.4

172.9

1500

4403

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

13.9

172.9

209

T92

ICPC

Gout

8.2

172.2

284

228

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.7

172.1

1150

2974

K90

ICPC

Stroke/cerebrovascular accident

6.0

172.1

367

404

321

Kela drug reimbursment

Paricalcitol and cinacalcet

30.5

171.9

158

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

6.4

171.9

346

357

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

64.7

171.5

138

U14

ICPC

Kidney symptom/complaint

9.5

171.1

256

178

WX730

NOMESCO Finland

Conventional respirator

7.0

171.0

321

305

QDB10, ,

SPAT

5.4

170.5

408

506

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

6.3

170.0

348

366

V03AE02

ATC

sevelamer; oral

268.0

169.8

204

ZXE40

NOMESCO Finland

More than seven and less than nine hours

5.5

169.4

394

475

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

10.8

169.3

234

143

A10BJ01

ATC

exenatide; parenteral

30.1

169.2

156

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

5.3

169.0

409

513

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

20.0

168.9

176

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

168.7

6075

28833

280

Kela drug reimbursment

Clopidogrel

170.9

168.1

207

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

645.3

167.8

196

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

18.7

167.8

179

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

15.5

167.7

193

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

167.6

887

2015

N06AB04

ATC

citalopram; systemic

2.0

167.1

2324

8250

WX213

NOMESCO Finland

Lower leg blockade

13.7

166.0

202

A11

ICPC

Chest pain NOS

2.9

165.1

945

2246

J45.1

ICD-10 Finland

Nonallergic asthma

2.9

164.9

895

2063

J01FA06

ATC

roxithromycin; oral

1.7

164.8

4580

20219

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.8

164.7

3254

12990

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.0

164.7

863

1949

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

14.8

164.2

193

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

28.1

164.1

154

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

423.2

163.4

193

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.3

163.0

507

796

L04AD01

ATC

ciclosporin; systemic

6.9

163.0

308

295

XF409

NOMESCO Finland

Other special ECG

37.5

162.9

143

C07AB04

ATC

acebutolol; systemic

37.5

162.9

143

A41.8

ICD-10 Finland

Other specified sepsis

5.9

162.3

354

399

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.6

161.7

629

1171

A10AD01

ATC

insulin (human); parenteral

8.8

161.2

254

191

N18

ICD-10 Finland

Chronic kidney disease

21.1

160.6

164

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

10.5

160.4

225

141

C02DE02, ,

ATC

22.0

159.8

161

L89

ICD-10 Finland

Decubitus ulcer and pressure area

5.9

159.7

348

392

XPX08

NOMESCO Finland

Intraoperative flow measurement

23.1

159.1

158

A10BD03

ATC

metformin and rosiglitazone; systemic

15.9

159.0

181

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.8

158.5

960

2353

E66

ICD-10 Finland

Obesity

3.9

157.7

557

966

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.7

157.5

979

2433

I95.9

ICD-10 Finland

Hypotension, unspecified

8.2

157.5

260

209

R07.3

ICD-10 Finland

Other chest pain

2.5

157.4

1206

3334

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.6

157.3

611

1136

K05

ICPC

Irregular heartbeat other

5.9

157.3

341

382

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.2

156.6

1615

5096

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.1

156.5

795

1761

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

25.9

156.4

150

3025

Kela drug reimbursment

Calcium carbonate

158.9

156.1

193

NGQ20

NOMESCO Finland

Amputation of lower leg

23.5

156.0

154

WX740

NOMESCO Finland

Nitrogen oxide therapy

50.1

155.9

130

AQ1

Conventional electrophysiological examination

18.5

155.0

166

C02EA03, ,

ATC

52.4

154.6

128

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

8.9

154.2

241

179

R95

ICPC

Chron obstructive pulmonary disease

4.5

154.2

453

678

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

154.0

2328

8486

B01AC07

ATC

dipyridamole; systemic

4.0

153.9

513

851

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

9.5

153.7

230

160

WX402

NOMESCO Finland

General anaesthesia

1.9

153.3

2701

10363

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

4.4

153.1

454

685

Z94.1

ICD-10 Finland

Heart transplant status

298.6

152.2

182

J46

ICD-10 Finland

Status asthmaticus

4.8

151.8

407

562

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

40.9

151.8

131

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.0

151.5

2057

7214

C09BA05

ATC

ramipril and diuretics; oral

138.3

151.3

189

ZXA05

NOMESCO Finland

Left side

1.8

150.5

2899

11432

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

28.7

150.0

140

M48.0

ICD-10 Finland

Spinal stenosis

2.3

149.7

1330

3933

EBA00

NOMESCO Finland

Extraction of tooth

1.7

149.1

4100

17930

R33

ICD-10 Finland

Retention of urine

2.6

149.0

1037

2731

GD2SN

NOMESCO Finland

Lung ventilation SPECT

16.5

148.3

166

ZXD00

NOMESCO Finland

Emergency procedure

4.7

148.2

405

569

A29

ICPC

General symptom/complaint other

2.2

148.0

1576

5032

A10BG02

ATC

rosiglitazone; oral

13.5

147.8

181

H02AB07

ATC

prednisone; oral

2.1

147.6

1699

5596

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

16.6

146.7

164

J01CA04

ATC

amoxicillin; systemic

1.7

146.6

9535

51918

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

5.6

145.6

332

392

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

9.1

145.0

222

160

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

44.8

144.8

123

PD4AD

NOMESCO Finland

CT of lower extremity arteries

12.7

144.3

182

C02LM02, ,

ATC

74.6

144.0

114

A01

ICPC

Pain general/multiple sites

2.4

143.8

1139

3193

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

5.4

143.8

339

414

A10BX01

ATC

guar gum; oral

4.7

143.4

398

567

UKC02

NOMESCO Finland

Cystoscopy

2.0

143.3

1861

6411

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

8.4

143.0

232

182

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

22.0

142.8

144

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

11.7

142.3

188

106

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

6.3

142.1

291

306

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

7.5

142.0

251

221

N06AA09

ATC

amitriptyline; systemic

2.5

141.7

1043

2822

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.2

141.7

649

1347

WZC00

NOMESCO Finland

Treatment plan or consultation

1.7

141.6

4305

19282

B82

ICPC

Anaemia other/unspecified

4.9

140.9

366

491

C02CA01

ATC

prazosin; oral

8.2

140.3

231

185

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

162.6

140.1

173

ZX108

NOMESCO Finland

Inhalation

10.7

140.0

194

119

212

Kela drug reimbursment

Gout

6.1

139.9

293

316

196

Kela drug reimbursment

Paricalcitol and cinacalcet

363.0

139.9

166

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.7

139.7

531

971

3A064, ,

NOMESCO Finland

57.4

139.5

114

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

10.5

138.7

194

121

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

30.8

138.5

127

J01CE08

ATC

benzathine benzylpenicillin; parenteral

9.1

138.2

213

155

B80

ICPC

Iron deficiency anaemia

5.6

137.9

316

375

PEN23

NOMESCO Finland

Plastic repair of femoral artery

23.9

137.5

135

SPAT1281

SPAT

Other administrative function

2.8

137.2

825

2010

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

136.8

8227

43460

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

60.6

136.8

111

XF602

NOMESCO Finland

Bloodpressure monitoring

11.2

136.6

185

109

AP2

Catheterization of the right side of the heart

52.8

136.6

113

H3601, E103,

ICD-10 Finland

16.6

136.2

152

J81

ICD-10 Finland

Pulmonary oedema

19.8

136.0

142

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

125.0

135.9

171

G04CA02

ATC

tamsulosin; oral

1.8

135.7

2787

11161

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.6

135.5

939

2464

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.6

135.5

944

2484

C08CA07

ATC

nisoldipine; oral

55.9

135.3

111

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.9

135.1

2068

7538

C09DX01

ATC

valsartan, amlodipine and hydrochlorothiazide; oral

214.4

135.1

164

I95.1

ICD-10 Finland

Orthostatic hypotension

4.0

134.9

458

770

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.9

134.8

726

1662

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.9

134.5

469

805

40199

ICD-8 Finland

Essential benign hypertension

8.9

134.4

210

156

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

134.3

1286

3920

ZXA10

NOMESCO Finland

Bilateral

1.9

134.3

2023

7333

AS2

Ventricular pacemaker insertion VVI (R)

38.3

133.9

117

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.4

133.8

1147

3331

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

1038.7

133.8

155

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

4.2

133.7

422

670

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.2

133.6

1397

4417

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

122.7

133.3

168

SPAT1234

SPAT

Support of social functional capacity

3.3

133.1

600

1232

H43.1

ICD-10 Finland

Vitreous haemorrhage

4.6

133.0

376

544

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

58.9

132.6

108

SPAT1312

SPAT

General health counselling

1.7

132.5

3119

12983

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

22.8

132.5

132

K04

ICPC

Palpitations/awareness of heart

3.6

132.2

506

930

H25.8

ICD-10 Finland

Other senile cataract

2.3

132.0

1198

3567

R4190

NOMESCO Finland

Nutritional therapy

3.3

131.8

596

1226

CKC15

NOMESCO Finland

Panretinal photocoagulation

15.3

131.7

152

J01AA02

ATC

doxycycline; systemic

1.6

131.6

9365

51306

E0000UV, ,

ATC

1.6

131.5

4612

21325

M79.6

ICD-10 Finland

Pain in limb

1.6

131.4

4806

22451

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

18.1

130.8

141

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

3.3

130.7

582

1185

R04.2

ICD-10 Finland

Haemoptysis

3.6

129.9

496

910

N30.0

ICD-10 Finland

Acute cystitis

2.0

129.6

1713

5924

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.8

129.4

749

1786

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

4.8

128.6

349

487

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.5

128.5

968

2645

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.8

128.2

749

1795

C09BA04

ATC

perindopril and diuretics; systemic

149.2

128.1

159

R4180

NOMESCO Finland

Podiatric therapy

7.9

127.9

217

181

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.8

127.6

2736

11069

H26.4

ICD-10 Finland

After-cataract

2.3

127.5

1118

3277

I34.01

ICD-10 Finland

Mitral (valve) regurgitation NOS or of specified cause, except rheumatic

24.6

127.4

124

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.6

127.2

883

2317

C02EA01, ,

ATC

16.0

127.1

144

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

13.3

126.5

156

A08AB01

ATC

orlistat; oral

24.4

126.1

123

WW200

NOMESCO Finland

Immunization

4.0

126.0

419

693

B03XA01

ATC

erythropoietin; parenteral

11.4

125.5

168

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

19.0

125.4

133

FN2CB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary chronic total occlusion

32.2

124.5

113

J94.8

ICD-10 Finland

Other specified pleural conditions

5.4

124.5

295

362

R4180, ,

SPAT

9.1

124.5

191

138

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.1

124.5

1430

4687

S20

ICPC

Corn/callosity

5.3

124.5

299

372

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

3.3

124.2

548

1109

SPAT1153

SPAT

Removal of sutures

1.7

123.9

3367

14536

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.5

123.6

929

2534

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.5

123.3

495

940

N02BF02

ATC

pregabalin; oral

2.7

123.2

793

2001

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

5.3

122.6

294

365

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

23.3

122.3

121

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

14.9

122.3

143

ZZA00

NOMESCO Finland

Split skin graft

4.0

122.2

408

677

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

5.4

121.9

287

350

SPAT1304

SPAT

Counselling and guidance related to ageing

2.8

121.5

728

1768

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.9

121.5

263

294

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.9

121.4

419

713

Z71.8

ICD-10 Finland

Other specified counselling

1.6

121.3

3605

15915

FN2AA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), balloon only

26.9

121.2

115

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

6.1

120.9

255

277

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

4.4

120.7

357

537

I95.2

ICD-10 Finland

Hypotension due to drugs

32.4

120.3

109

C07AA03

ATC

pindolol; systemic

16.6

120.0

134

342

Kela drug reimbursment

Dronedarone

462.0

119.7

141

A10AB06

ATC

insulin glulisine; parenteral

13.0

119.6

149

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

6.0

118.3

253

279

XG410

NOMESCO Finland

Flow-volume spirometry

3.3

118.3

513

1026

WW500

NOMESCO Finland

Blood transfusion

3.0

118.0

598

1319

FPE40

NOMESCO Finland

Replacement of transvenous cardiac pacemaker electrode

28.8

118.0

110

R96

ICPC

Asthma

2.3

117.4

1048

3092

GD1UN

NOMESCO Finland

Lung circulation SPECT

17.3

117.4

129

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.8

117.3

313

430

R05FB02

ATC

cough suppressants and expectorants; systemic

1.6

116.9

4157

19152

B01AB04

ATC

dalteparin; parenteral

2.9

116.5

642

1487

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.2

116.3

1197

3751

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

30.2

115.0

106

J96.9

ICD-10 Finland

Respiratory failure, unspecified

10.6

114.9

160

D64.8

ICD-10 Finland

Other specified anaemias

5.7

114.7

257

298

C10AA02

ATC

lovastatin; oral

4.4

114.6

342

518

C09BB04

ATC

perindopril and amlodipine; systemic

60.8

114.6

A07AA09

ATC

vancomycin; oral

5.9

114.2

248

278

V03AE03

ATC

lanthanum carbonate; oral

225.2

114.0

138

TFJ02

NOMESCO Finland

Muscle biopsy of heart

296.4

113.7

136

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.9

113.7

641

1504

OAA67, ,

SPAT

0.4

113.2

531

8750

R05

ICPC

Cough

1.7

113.1

2594

10652

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

10.8

113.1

156

K74

ICPC

Ischaemic heart dis with angina

16.5

112.6

126

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

112.4

2060

7918

315

Kela drug reimbursment

Clopidogrel

16.7

112.3

125

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

8.0

112.3

189

156

Z3229

NOMESCO Finland

Other healthcare associate professional

2.3

112.1

960

2779

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.8

112.1

398

692

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

11.9

111.0

145

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

3.6

110.7

425

782

XF622

NOMESCO Finland

Measurement of minute volume of heart

24.4

110.7

108

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

+∞

110.4

126

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.6

110.2

3561

15980

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

17.5

109.7

120

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.8

109.6

387

670

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

16.6

109.5

122

B01AB10

ATC

tinzaparin; parenteral

2.1

109.2

1318

4391

N06AX21

ATC

duloxetine; oral

2.2

109.2

1155

3656

K22

ICPC

Risk factor cardiovascular disease

2.8

109.1

648

1565

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.5

109.0

773

2047

A02BC03

ATC

lansoprazole; oral

1.7

108.6

3014

13009

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.2

108.2

1091

3386

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.3

108.1

1006

3019

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.4

107.9

843

2339

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.3

107.8

464

923

I48.4

ICD-10 Finland

Atypical atrial flutter

100.6

107.7

138

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

106.9

3809

17475

A99

ICPC

Disease/condition unspecnature/site

2.1

106.5

1133

3593

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

106.2

1161

3721

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

19.6

106.1

111

FPJ24

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

106.0

121

Z51.5

ICD-10 Finland

Palliative care

2.1

105.4

1153

3696

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.1

105.3

515

1111

I45.9

ICD-10 Finland

Conduction disorder, unspecified

10.8

105.3

145

I20.9

ICD-10 Finland

Angina pectoris, unspecified

10.8

105.3

145

N02BF01

ATC

gabapentin; oral

2.2

105.3

1061

3291

NF1AA

NOMESCO Finland

Hip X-ray examination

2.2

105.1

1067

3319

TGC00

NOMESCO Finland

Bronchial lavation

3.6

104.9

404

745

C02DE10, ,

ATC

37.6

104.8

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

8.2

104.8

173

139

R60.1

ICD-10 Finland

Generalized oedema

11.5

104.7

139

SPAT1151

SPAT

Treatment of major wounds

6.8

104.6

199

192

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

272.1

104.2

125

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

3.0

104.2

530

1171

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

96.9

103.4

133

AB2

AVR bio, stent

47.4

103.4

TK820

NOMESCO Finland

Peritoneal dialysis

399.0

103.2

122

N06AX16

ATC

venlafaxine; oral

2.0

102.7

1375

4752

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.0

102.5

1420

4967

R06.2

ICD-10 Finland

Wheezing

3.0

102.3

523

1159

A02BA02

ATC

ranitidine; systemic

1.8

102.0

2062

8139

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

9.9

102.0

148

FXG00

NOMESCO Finland

Insertion and use of IABP

46.8

102.0

H3600, E103,

ICD-10 Finland

9.2

101.6

155

111

FC1AC

NOMESCO Finland

Angiography of thoracal aortta

27.3

101.6

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

7.4

101.1

180

160

5253

FHL

Cardiac lung machine

16.4

100.9

113

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

4.9

100.7

261

349

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

7.8

100.6

172

145

FN2CC

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of left main trunk

22.0

100.3

101

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

13.9

100.3

121

I44.0

ICD-10 Finland

Atrioventricular block, first degree

6.5

100.2

199

202

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

136.5

100.1

125

H03BB01

ATC

carbimazole; oral

3.2

100.1

450

921

E05.89

ICD-10 Finland

Other thyrotoxicosis

23.1

99.9

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

3.8

99.3

356

623

NFQ20

NOMESCO Finland

Amputation of femur

10.7

98.9

137

L04AX01

ATC

azathioprine; systemic

2.9

98.7

542

1252

D07AC01

ATC

betamethasone; topical

1.5

98.6

3970

18656

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.9

98.3

1474

5294

WX720

NOMESCO Finland

Own respiration

2.8

98.2

563

1332

K92

ICPC

Atherosclerosis/periph vascular dis

8.7

98.1

155

117

R06

ICPC

Nose bleed/epistaxis

4.7

98.0

269

379

C01BD07

ATC

dronedarone; oral

379.1

97.9

116

Q23.11

ICD-10 Finland

Bicuspid aortic valve

9.5

97.9

146

101

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

6.7

97.7

188

184

R4120

NOMESCO Finland

Occupational therapy

2.4

97.5

751

2067

FNC40

NOMESCO Finland

Aorto-coronary venous bypass with four distal anastomoses

133.2

97.5

122

SPAT1139

SPAT

Nutrition survey

3.9

97.5

338

577

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

4.5

97.4

279

408

C02DE01, ,

ATC

19.6

97.4

102

R03BA05

ATC

fluticasone; inhalant

1.8

97.4

1849

7156

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

8.3

97.3

159

126

C09CA08

ATC

olmesartan medoxomil; oral

115.1

97.2

123

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

20.4

96.9

100

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

31.9

96.8

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.5

96.6

717

1939

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

6.2

96.6

200

213

K05.31

ICD-10 Finland

Periodontitis pronounced

2.0

96.5

1326

4620

R00.0

ICD-10 Finland

Tachycardia, unspecified

3.6

96.4

365

665

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

96.3

1058

3393

SPAT1101

SPAT

Orthostatic test

3.5

96.0

380

714

SPAT1053

SPAT

Memory test

2.0

96.0

1240

4226

H03AA01

ATC

levothyroxine sodium; systemic

1.7

95.9

2312

9573

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.7

95.4

359

651

J45.8

ICD-10 Finland

Mixed asthma

3.5

95.2

374

699

L04AA01

ATC

[U] ciclosporin

5.6

95.1

216

254

C08CA03

ATC

isradipine; systemic

190.8

95.0

116

FKC50

NOMESCO Finland

Repair of mitral valve for insufficiency using prosthetic chord

25.9

94.9

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

153.3

94.5

117

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

3.9

94.4

319

534

WX100

NOMESCO Finland

Conjunctival surface anesthesia

2.0

94.0

1295

4513

XW000

NOMESCO Finland

Bone marrow biopsy

2.8

93.9

545

1298

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.2

93.7

883

2659

W19

ICD-10 Finland

Unspecified fall

2.0

93.7

1166

3919

5315

FHL

Bypass surgery using a mammary artery

19.0

93.6

CKC12

NOMESCO Finland

Photocoagulation of retina

2.7

93.4

564

1373

R18

ICD-10 Finland

Ascites

3.8

93.3

332

578

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

5.0

93.2

240

319

RS221, ,

NOMESCO Finland

5.3

93.0

221

272

CKC10

NOMESCO Finland

Local photocoagulation of retina

5.1

93.0

233

302

A02BC05

ATC

esomeprazole; systemic

1.5

92.9

4318

20873

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

92.8

2612

11249

K65.0

ICD-10 Finland

Acute peritonitis

5.5

92.8

215

258

WX780

NOMESCO Finland

Remote monitoring CPAP

2.9

92.8

511

1182

M01AB01

ATC

indometacin; systemic, rectal

2.3

92.7

832

2453

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

92.4

2231

9231

N05AX08

ATC

risperidone; systemic

2.2

92.4

952

2974

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.6

92.4

354

650

ZYC01

NOMESCO Finland

Remote contact by phone

2.4

92.4

717

1980

288

Kela drug reimbursment

Febuxostat

40.2

92.3

AQ2

Electrophysiological electroanatomical examination

46.3

92.3

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

7.1

92.1

169

156

C10AB02

ATC

bezafibrate; oral

10.9

91.8

126

-50

ICPC

Medication/prescr/renewal

3.2

91.6

430

904

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

4.4

91.6

269

402

G04BE03

ATC

sildenafil; oral

4.5

91.5

266

394

WVA20

NOMESCO Finland

Medicine administration

3.5

91.0

364

689

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

8.1

90.6

150

121

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.5

90.5

360

679

S10

ICPC

Boil/carbuncle

2.5

90.4

656

1754

OAB42, ,

SPAT

2.0

90.3

1143

3863

U04

ICPC

Incontinence urine

2.6

90.2

587

1486

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

3.8

90.1

315

541

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

4.6

89.8

252

362

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

3.0

89.8

454

999

R03BA01

ATC

beclometasone; inhalant

1.9

89.7

1439

5274

R03BA02

ATC

budesonide; inhalant

1.7

89.6

1842

7282

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

49.0

89.6

Z95.4

ICD-10 Finland

Presence of other heart-valve replacement

45.1

89.6

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.7

89.5

555

1370

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

346.1

89.2

106

WW502

NOMESCO Finland

Autotransfusion

17.6

89.1

SPAT1245

SPAT

Provision of support and information to patient’s family members

3.1

88.6

431

926

I20

ICD-10 Finland

Angina pectoris

8.9

88.6

138

102

N05AA02

ATC

levomepromazine; systemic

2.8

88.6

527

1272

N30.9

ICD-10 Finland

Cystitis, unspecified

2.4

88.4

707

1979

R41.0

ICD-10 Finland

Disorientation, unspecified

3.5

88.3

355

674

I21.39

ICD-10 Finland

Acute transmural myocardial infarction with unspecified localization unspecified coronary artery status

17.1

88.1

PD3AT

NOMESCO Finland

Pelvic artery PTA

17.1

88.1

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

10.6

88.0

122

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

87.7

2204

9205

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

3.4

87.6

360

694

A40.8

ICD-10 Finland

Other streptococcal sepsis

7.2

87.5

158

143

SPAT1054

SPAT

Examination of peripheral nervous system

6.5

87.5

174

177

F05.9

ICD-10 Finland

Delirium, unspecified

4.1

87.4

283

458

AP4

Myocardial biopsy

666.9

87.4

102

QXB99, ,

SPAT

3.4

87.1

361

700

TFP32

NOMESCO Finland

Cathetric treatmen of cardiac arrythmia

20.8

86.7

I20.0

ICD-10 Finland

Unstable angina

14.3

86.7

103

R03DA04

ATC

theophylline; systemic, rectal

2.4

86.4

695

1950

H02AB09

ATC

hydrocortisone; systemic

3.7

86.3

322

580

B03BA03

ATC

hydroxocobalamin; parenteral

2.5

86.0

606

1597

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

9.7

85.9

126

SPAT1257

SPAT

Teaching of medicine inhalation technique

3.4

85.8

353

681

FXL00

NOMESCO Finland

Insertion and use of extra-, para- or intracorporeal VAD

653.7

85.7

100

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

117.8

85.6

108

B04AB02, ,

ATC

6.8

85.4

163

158

N07BB01

ATC

disulfiram; oral

2.7

84.8

513

1249

J45

ICD-10 Finland

Asthma

2.0

84.6

1011

3343

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

3.9

84.1

286

481

I21.91

ICD-10 Finland

Myocardial infarction (acute) UNS stenosed coronary artery

42.7

84.0

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

83.8

3160

14532

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.2

83.6

841

2599

H04AA01

ATC

glucagon; nasal, parenteral

4.6

83.3

233

334

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

5.1

83.2

206

264

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.0

83.1

421

927

Electrophysiological Special Examination

14.6

83.1

AR6

Catheter ablation of arrhythmia, target: atrial fibrillation

42.1

82.7

R03AC13

ATC

formoterol; inhalant

2.6

82.6

554

1424

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

11.8

82.4

108

M13.9

ICD-10 Finland

Arthritis, unspecified

2.1

82.3

856

2681

C07BB02

ATC

metoprolol and thiazides; systemic

319.6

82.3

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

82.2

1406

5251

WX212

NOMESCO Finland

Femoral plexus blockade

3.7

82.2

300

532

WX320

NOMESCO Finland

Spinalanesthesy

1.6

82.1

2554

11230

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

9.1

81.7

125

EBA30

NOMESCO Finland

Extraction of root of tooth

2.3

81.7

684

1954

UJF92

NOMESCO Finland

Capsular endoscopy

4.1

81.6

264

427

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

15.4

81.6

SPAT1058

SPAT

PEF monitoring instruction

2.3

81.5

741

2195

FPW96

NOMESCO Finland

Other operation for arhythmia or disturbance of impulse propagation

16.5

81.4

RD210, ,

NOMESCO Finland

4.8

81.4

217

298

E87.2

ICD-10 Finland

Acidosis

13.9

81.4

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

5.8

81.4

177

199

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.0

81.2

998

3332

I21.21

ICD-10 Finland

Acute transmural myocardial infarction with another location stenosed coronary artery

25.5

81.0

Initial pacemaker installation

18.7

80.8

AS7

Arrhythmia pacemaker insertion VVI (R) S

+∞

80.6

I11

ICD-10 Finland

Hypertensive heart disease

313.0

80.5

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.5

80.4

564

1482

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

7.8

80.4

137

115

A10BD20

ATC

metformin and empagliflozin; oral

7.4

80.4

143

127

XFN00

NOMESCO Finland

Inside imaging of coronary arteries??

30.2

80.3

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

5.6

80.3

183

216

L14

ICPC

Leg/thigh symptom/complaint

2.1

80.2

868

2761

M04AA03

ATC

febuxostat; oral

35.6

80.0

SPAT1285

SPAT

Provision of consultation response

2.7

80.0

500

1239

M54.5

ICD-10 Finland

Low back pain

1.5

79.9

3706

17777

I97.0

ICD-10 Finland

Postcardiotomy syndrome

38.1

79.9

R03AC12

ATC

salmeterol; inhalant

2.6

79.9

529

1350

JN4BD

NOMESCO Finland

Extensive body CT

1.9

79.8

1269

4629

SPAT1231

SPAT

Assessment of adjustments needed in living environment

4.7

79.7

216

301

E000001, ,

ATC

1.7

79.3

1948

8066

C03EA02

ATC

trichlormethiazide and potassium-sparing agents; oral

5.9

79.0

170

189

D50.8

ICD-10 Finland

Other iron deficiency anaemias

5.1

78.9

196

252

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.6

78.8

296

536

R03AK08

ATC

formoterol and beclometasone; inhalant

2.7

78.2

483

1189

R81

ICPC

Pneumonia

2.8

77.9

464

1120

C10AB05

ATC

fenofibrate; oral

5.1

77.9

194

250

FXZ00

NOMESCO Finland

Off-pump cardiac operation

107.9

77.9

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.4

77.7

617

1720

K01

ICPC

Heart pain

7.7

77.4

133

113

M10.3

ICD-10 Finland

Gout due to impairment of renal function

126.9

77.4

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

3.9

77.2

261

437

FM1TQ

NOMESCO Finland

Heart perfusion SPECT with low dose CT at rest and with exercise

23.6

77.2

WX870

NOMESCO Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3005719) IgG [Mass/volume] in Serum or Plasma

1810

4324

2.99

322.13

3.2

3.1

10.54

g/l

0.02

1717

3983

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

718

839

5.82

319.95

4.4

2.2

2986.54

19078.81

u/ml

0.79

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1121

1952

3.98

319.89

2.3

2.6

3.11

2.80

g/l

15.20

1041

1766

(3010375) cycloSPORINE [Mass/volume] in Blood

307

25.49

317.98

31.7

25.1

115.94

144.34

ug/l

3.20

209

(3045788) Cell count panel - Pleural fluid

508

401

8.52

312.55

1.5

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2970

9321

2.38

310.06

4.3

2.7

2.89

2.04

e6/l

4.25

1592

4299

(3015377) Calcium [Moles/volume] in Serum or Plasma

5339

20861

2.12

307.65

4.7

3.9

2.33

2.35

mmol/l

22.78

4894

18975

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2313

2775

6.36

307.65

18.2

8.6

1.43

1.33

3.03

2298

2761

(3044640) Blood type and Crossmatch panel - Blood

5556

18697

2.61

307.65

3.9

2.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1193

2045

4.07

307.65

2.3

2.6

3.75

3.74

g/l

0.07

1113

1860

(3027945) Reticulocytes/Erythrocytes in Blood

3391

5146

5.42

307.65

3.3

2.8

2.07

1.65

57.34

3144

4616

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1531

1859

5.92

307.65

2.4

1.8

2.31

2.63

ug/l

0.16

1411

1652

(3042936) Bacteria identified in Isolate by Culture

3740

7629

4.06

307.65

3.1

1.8

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1974

2372

6.18

307.65

6.0

3.0

2.54

1.81

mmol/l

9.07

1520

1827

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6823

24801

2.64

307.65

2.6

1.8

92.49

97.00

pmol/l

11.36

4061

12416

(3044889) 12 lead EKG panel

9270

40602

2.65

307.65

7.9

2.7

1207.29

0.45

0.48

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1587

2022

5.66

307.65

6.1

2.3

0.60

0.65

4.75

1578

2013

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1192

2046

4.06

307.65

2.3

2.6

4.20

4.22

g/l

0.21

1113

1861

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5346

6029

9.04

307.65

4.5

1.8

20.51

24.98

61.00

5145

5562

(3003181) Sodium [Moles/volume] in Urine

628

621

6.85

307.65

1.5

1.3

55.77

67.38

mmol/l

5.32

477

479

(3024928) Oxygen saturation in Venous blood

1000

851

8.18

307.65

6.2

2.5

63.24

61.63

0.95

970

828

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

857

1165

5.04

307.65

1.7

1.3

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

9487

45988

2.23

307.65

6.5

3.8

18.87

10.32

mm/h

314.63

9002

42819

(3014007) Fractional oxyhemoglobin in Arterial blood

2332

2782

6.40

307.65

18.4

8.7

92.68

94.58

25.15

2318

2777

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3526

5325

5.51

307.65

2.5

1.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3141

2293

11.38

307.65

5.3

1.9

380.34

89.71

ng/l

75.38

3003

2047

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1033

1306

5.49

307.65

1.8

1.7

—

(3019069) Monocytes/Leukocytes in Blood

7830

28418

2.96

307.65

10.0

6.6

9.11

8.93

5.80

7536

26640

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2721

2597

8.32

307.65

3.3

1.7

13.80

5.97

ug/l

13.70

2481

2175

(3010421) pH of Blood

1090

1361

5.58

307.65

7.0

2.5

7.41

1.75

1077

1338

(3042733) HLA Ab [Presence] in Serum

356

65.96

307.65

5.4

3.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5604

18318

2.72

307.65

4.0

2.5

68.26

67.08

u/l

0.03

5319

16915

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4398

14008

2.56

307.65

3.8

2.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1023

939

7.59

307.65

3.4

2.2

33.64

34.07

umol/l

0.12

943

845

(3013826) Glucose [Moles/volume] in Serum or Plasma

9765

31846

4.90

307.65

12.6

3.8

7.31

6.34

mmol/l

269.52

9567

30235

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7700

25375

3.36

307.65

5.1

2.4

180.09

143.22

ug/l

9.44

7335

23682

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5679

19168

2.63

307.65

4.3

3.2

42.70

34.92

u/l

2.47

5372

18184

(3018010) Neutrophils/Leukocytes in Blood

7739

28671

2.84

307.65

9.7

6.3

61.84

55.87

314.23

7528

27342

(3018095) Leukocytes [#/volume] in Urine

6253

21281

2.74

307.65

6.2

3.3

104.29

94.12

e6/l

0.40

4959

14367

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1046

1430

5.07

307.65

2.2

1.6

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1138

1830

4.33

307.65

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

6214

10866

6.16

307.65

4.7

2.7

6.76

8.07

mmol/l

76.95

5352

9148

(3037467) Urinalysis macro (dipstick) panel - Urine

9037

39643

2.55

307.65

7.0

3.7

2.15

3.03

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2303

5346

3.18

307.65

5.2

2.9

—

(3019977) pH of Arterial blood

3960

5032

6.89

307.65

14.1

6.6

7.41

7.42

6.12

2198

2621

(3036489) Thrombin time

1162

1841

4.40

307.65

4.2

2.0

22.05

20.55

7.80

1086

1621

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1893

1603

8.79

307.65

2.0

1.7

1.58

1.49

g/l

2.15

1657

1355

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

10574

48174

3.21

307.65

14.9

7.9

87.74

79.35

u/l

46.26

10326

45648

(3022948) Iron [Moles/volume] in Serum or Plasma

5696

7220

8.30

307.65

4.5

1.8

11.55

14.33

umol/l

97.12

5486

6705

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1035

1284

5.60

307.65

5.4

2.7

2.14

1.12

mg/l

137.30

965

1181

(3030467) Casts [#/volume] in Urine by Automated count

5204

15756

2.90

307.65

5.0

2.7

0.75

0.34

e6/l

15.90

4170

10969

(3021960) Folate [Moles/volume] in Serum or Plasma

5160

14799

3.09

307.65

2.1

1.5

18.68

20.99

nmol/l

21.07

4589

12349

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1958

2452

5.92

307.65

11.1

5.8

24.80

24.88

mmol/l

0.27

1900

2328

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1414

1577

6.40

307.65

3.8

1.8

585.82

410.72

ug/l

0.77

1375

1467

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3984

5028

6.96

307.65

13.9

6.7

5.21

5.16

kpa

1.34

3861

4827

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1371

2353

4.11

307.65

2.3

1.9

35.81

43.04

u/l

20.14

1077

2223

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2148

3580

4.46

307.65

2.1

1.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3571

5866

5.06

307.65

6.3

5.8

263.64

245.48

u/l

5.30

3453

5574

(3000850) Epithelial cells [#/volume] in Urine

4460

11878

3.18

307.65

4.2

2.2

5.38

4.77

e6/l

2.37

4189

10750

(3032080) INR in Blood by Coagulation assay

9553

23473

7.08

307.65

34.0

5.8

1.50

1.10

inr

307.65

8534

18837

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1515

1992

5.45

307.65

6.8

2.8

48.88

47.60

0.86

1486

1971

(3020876) Protein [Mass/time] in 24 hour Urine

526

354

10.01

307.65

2.5

2.7

1.60

0.64

g/24h

7.73

355

185

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

6106

11744

5.45

307.65

3.3

2.0

3.23

2.70

mg/l

33.62

5564

9907

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1450

1310

7.96

307.65

4.7

2.4

25.18

25.24

mmol/l

0.16

1427

1289

(3028271) Lactate [Moles/volume] in Capillary blood

652

625

7.07

307.65

2.5

1.5

1.65

1.71

mmol/l

0.51

638

606

(3015736) pH of Urine

5945

23996

2.11

307.65

4.7

2.8

6.22

6.18

1.35

3161

13593

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1934

2526

5.66

307.65

19.5

8.1

15.49

16.50

30.56

1897

2419

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2323

2982

5.93

307.65

16.5

6.7

24.92

25.10

mmol/l

1.00

2308

2958

(3014111) Lactate [Moles/volume] in Serum or Plasma

2990

4105

5.83

307.65

15.8

6.4

1.42

1.28

mmol/l

6.60

2939

4024

(3006315) Basophils [#/volume] in Blood

8383

30583

3.17

307.65

9.4

6.3

0.04

e9/l

6.45

7403

26116

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2248

2711

6.29

307.65

18.9

8.8

0.60

0.65

3.62

2234

2698

(3013290) Carbon dioxide [Partial pressure] in Blood

824

832

6.79

307.65

7.1

2.8

5.09

5.03

kpa

0.83

807

809

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

887

1123

5.43

307.65

10.4

3.8

1026.08

383.14

iu/ml

1.42

206

118

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2105

3058

5.13

307.65

7.0

2.2

139.71

63.47

ng/l

105.69

1856

2610

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1060

1394

5.28

307.65

2.5

1.9

12.72

10.50

mg/l

4.33

1001

1305

(3012095) Magnesium [Moles/volume] in Serum or Plasma

4918

8352

5.52

307.65

6.2

3.6

0.81

0.83

mmol/l

16.50

4739

7822

(3043409) Potassium [Moles/volume] in Arterial blood

871

1003

5.97

307.65

7.2

3.7

3.99

3.83

mmol/l

11.91

862

996

(3027315) Oxygen [Partial pressure] in Blood

850

834

7.01

307.65

7.0

2.8

8.22

8.78

kpa

10.04

833

811

(3002030) Lymphocytes/Leukocytes in Blood

7861

29186

2.87

307.65

10.0

6.4

22.90

29.09

307.65

7620

27688

(3024561) Albumin [Mass/volume] in Serum or Plasma

8098

25608

3.76

307.65

9.0

4.6

33.24

35.93

g/l

264.36

7763

23917

(3002032) Base excess in Venous blood by calculation

3360

3817

7.34

307.65

7.6

2.7

1.98

2.20

mmol/l

1.80

2990

3382

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

9477

45318

2.30

307.65

5.3

3.8

15.41

14.55

pmol/l

164.27

8872

41396

(3034860) Kappa light chains.free [Mass/volume] in Serum

1218

1395

6.15

307.65

3.2

4.4

63.27

43.58

mg/l

2.66

1000

1213

(3004119) Hemoglobin [Mass/volume] in Venous blood

1942

2398

6.00

307.65

6.4

2.4

122.78

132.11

g/l

37.27

1878

2344

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

727

602

8.24

307.65

8.8

5.6

12.09

10.96

mg/l

5.82

683

560

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1035

1613

4.44

307.65

7.3

3.3

25.04

25.10

mmol/l

0.20

982

1489

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4254

5828

6.54

307.65

12.3

3.9

1.12

1.00

mmol/l

86.37

4066

5336

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3176

9968

2.41

307.65

4.1

2.6

1.16

1.30

e6/l

0.18

1804

4974

(3028026) IgM [Mass/volume] in Serum or Plasma

1543

3302

3.31

307.65

2.1

1.16

1.47

g/l

5.11

1445

3016

(3026008) Bacteria identified in Urine by Culture

5418

14944

3.31

307.65

4.2

2.8

—

(3009261) Glucose [Presence] in Urine by Test strip

7272

30975

2.18

307.65

5.7

3.1

0.02

0.01

estimate

1.11

1690

5769

(3026493) Urate [Moles/volume] in Serum or Plasma

5082

13530

3.35

307.65

4.3

2.2

397.68

316.54

umol/l

307.65

4548

12055

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1290

1924

4.72

307.65

7.6

4.1

1.76

1.65

2.08

1239

1805

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

829

1036

5.48

307.65

1.6

1.8

—

(3023199) Leukocytes [#/volume] in Pleural fluid

619

525

7.98

307.65

1.6

1.4

3827.16

4286.51

e6/l

0.09

440

373

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8871

28617

4.14

307.65

17.7

5.5

1.19

1.22

mmol/l

241.62

7877

24323

(3021589) Normoblasts [#/volume] in Blood

6785

27426

2.26

307.65

22.1

9.7

0.00

e9/l

0.19

5633

22138

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3762

5708

5.60

307.65

2.4

1.7

—

(3020630) Protein [Mass/volume] in Serum or Plasma

2599

4150

4.82

307.65

2.6

3.1

64.53

66.71

g/l

26.85

2456

3805

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7025

27325

2.44

307.65

4.3

2.5

—

estimate

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2613

5492

3.61

307.65

2.6

2.3

0.19

0.21

g/l

34.29

2423

5149

(3000991) Gas panel - Venous blood

3044

3630

6.79

307.65

18.0

7.3

—

(3013512) EKG study

5621

18339

2.73

307.65

6.4

2.5

0.75

0.73

0.05

(3009343) pH of Capillary blood

2199

2705

6.14

307.65

6.5

3.0

7.41

7.42

11.57

1925

2237

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

639

416

10.43

307.65

2.7

2.0

240.01

24.04

ug/min

11.72

406

208

(3007930) Methemoglobin/Hemoglobin.total in Blood

1167

1738

4.69

307.65

8.1

4.4

0.83

0.90

5.51

1119

1621

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1215

1392

6.14

307.65

3.2

4.4

59.71

31.48

mg/l

2.15

990

1213

(3006504) Eosinophils/Leukocytes in Blood

7814

28366

2.96

307.65

9.9

6.5

2.63

2.92

23.08

7514

26579

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1193

2048

4.06

307.65

2.3

2.6

7.60

7.04

g/l

16.97

1115

1861

(3012501) Base excess in Blood by calculation

823

832

6.79

307.65

7.1

2.8

2.94

2.52

mmol/l

2.46

609

592

(3007853) Bacteria identified in Skin by Aerobe culture

2941

5966

3.84

307.65

2.6

1.6

—

(3022096) Basophils/Leukocytes in Blood

7797

28379

2.94

307.65

10.0

6.5

0.63

0.71

27.67

7505

26569

(3016502) Oxygen saturation in Arterial blood

3645

4330

7.19

307.65

14.2

7.1

94.33

96.29

41.46

3547

4176

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

8230

25528

3.94

307.65

16.3

5.0

1.19

1.22

mmol/l

184.24

7866

23372

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4737

8573

5.05

307.65

7.3

2.4

868.89

207.80

ng/l

2.88

4431

5929

(3020779) Urea [Moles/volume] in Serum or Plasma

3690

3191

10.06

307.65

17.4

4.0

12.58

7.25

mmol/l

190.37

3584

3066

(3006184) Hemoglobin [Mass/volume] in Capillary blood

895

1062

5.80

307.65

3.5

1.7

126.54

132.14

g/l

5.56

714

757

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2496

6696

2.75

307.65

3.4

2.7

9.75

9.83

umol/l

0.05

2213

5910

(3019309) Folate [Moles/volume] in Red Blood Cells

3385

8180

3.27

307.65

2.0

1.6

1251.69

1136.49

nmol/l

8.00

2709

6067

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4798

7871

5.67

307.65

2.6

1.8

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3432

10605

2.49

307.65

1.9

1.6

8749602.10

39208795.17

pmol/l

4.09

2926

8817

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1483

2908

3.61

307.65

3.9

3.1

4.22

4.51

pmol/l

16.38

1383

2587

(3018677) aPTT in Platelet poor plasma by Coagulation assay

4046

6691

5.23

307.65

4.3

1.9

31.23

28.90

70.91

3955

6507

(3001604) Monocytes [#/volume] in Blood

8367

30488

3.17

307.65

9.4

6.3

0.66

0.56

e9/l

150.22

7398

26040

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3277

4120

6.55

307.65

15.5

7.4

119.48

123.15

g/l

12.50

3231

4009

(3024354) Oxygen [Partial pressure] in Venous blood

2712

3336

6.40

307.65

6.1

2.5

4.71

4.55

kpa

2.31

2628

3257

(1616796) Gas panel - Central venous blood

977

821

8.27

307.65

6.6

2.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1529

2408

4.53

307.65

1.8

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1459

1735

6.02

307.65

6.4

2.5

25.39

25.62

mmol/l

1.05

1414

1689

(40767503) Oxygen content in Capillary blood by calculation

878

829

7.30

307.65

4.3

2.0

15.82

16.64

7.29

861

811

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1355

2056

4.66

307.65

1.3

1.5

8.88

14.31

iu/ml

0.58

(3023520) Reticulocytes [#/volume] in Blood

2742

3891

5.52

307.65

3.3

3.0

76.81

66.35

e9/l

20.32

2084

2857

(3023368) Bacteria identified in Blood by Culture

6867

14311

5.45

307.65

7.2

4.0

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

5573

6675

8.70

307.65

4.5

1.7

2.30

g/l

0.12

5347

6127

(36304419) Bacteria [Presence] in Urine

4862

15097

2.74

307.65

4.9

2.7

28.16

11.81

estimate

0.23

(3026250) Tacrolimus [Mass/volume] in Blood

415

48.78

307.65

46.9

29.7

7.45

7.22

ug/l

0.35

383

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2280

2774

6.25

307.65

6.5

3.1

5.30

5.17

kpa

5.61

2218

2633

(3028626) Oxygen [Partial pressure] in Capillary blood

1123

938

8.41

307.65

5.1

3.0

7.94

8.27

kpa

5.58

1101

915

(3018405) Lactate [Moles/volume] in Arterial blood

1103

1195

6.45

307.65

6.2

3.5

1.42

mmol/l

0.01

1081

1170

(3003434) Protein [Mass/volume] in Pleural fluid

736

547

9.20

307.65

1.6

1.4

27.51

38.73

g/l

60.84

633

515

(3003396) Base excess in Arterial blood by calculation

3938

5002

6.88

307.65

13.9

6.6

1.24

1.09

mmol/l

1.03

3391

4165

(3020682) Albumin/Creatinine [Ratio] in Urine

6207

9759

6.95

307.65

5.6

3.2

23.50

3.59

mg/mmol

59.14

4568

4971

(3002582) Erythrocytes [#/volume] in Urine

5938

18332

3.02

307.65

5.2

2.8

78.88

64.32

e6/l

0.46

4905

13500

(3027801) Oxygen [Partial pressure] in Arterial blood

3983

5026

6.96

307.65

13.9

6.7

10.87

13.69

kpa

133.73

3851

4833

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

988

1449

4.71

307.65

5.0

2.3

226.58

183.86

28.75

951

1373

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1109

1234

6.28

307.65

3.0

4.2

2.27

6.75

ratio

1.39

642

734

(3019060) Gas panel - Arterial blood

2143

2347

6.89

307.65

6.4

4.2

—

(3020891) Body temperature

1445

1804

5.72

307.65

8.2

3.5

36.94

36.89

°c

2.90

1416

1787

(3017143) Hepatitis C virus Ab [Presence] in Serum

2225

5867

2.76

307.65

2.2

1.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

7173

30246

2.19

307.65

5.6

3.1

0.00

estimate

0.47

1870

5779

(3021901) Oxygen saturation in Capillary blood

981

755

9.04

307.65

4.7

2.4

88.92

90.39

5.74

959

737

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3443

3911

7.40

307.65

7.6

2.7

5.98

5.84

kpa

7.44

3357

3824

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1803

1053

12.73

307.65

4.9

2.6

0.33

0.35

iu/ml

0.88

1090

535

(3019198) Lymphocytes [#/volume] in Blood

8442

31243

3.12

307.65

9.5

6.3

1.73

1.91

e9/l

11.18

7569

27315

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2090

4574

3.34

307.65

2.4

2.7

366.12

384.52

nmol/l

2.70

1946

4282

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1057

1290

5.70

307.65

1.4

1.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4648

11201

3.63

307.65

3.7

1.6

1.54

1.21

mg/l

5.96

3900

8722

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2229

2203

7.71

307.65

7.7

2.8

24.12

24.72

mmol/l

9.06

2205

2185

(3033658) Prothrombin time (PT) actual/Normal

4734

15127

2.62

307.65

7.9

3.5

76.23

93.65

287.84

4647

14811

(3012544) pH of Venous blood

3480

3927

7.47

307.65

7.6

2.7

7.37

7.38

3.63

2223

2219

(3013115) Eosinophils [#/volume] in Blood

8513

31621

3.14

307.65

9.9

6.5

0.19

e9/l

3.44

7579

27365

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2310

2682

6.58

307.65

17.1

8.3

24.35

24.53

mmol/l

1.18

2265

2636

(3031040) Bacteria [#/volume] in Urine by Automated count

9070

37818

2.81

307.65

6.9

3.7

1280.70

1734.26

e6/l

0.36

162

544

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

9173

30942

4.09

307.65

10.6

7.1

12.99

11.45

umol/l

20.18

8905

29472

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1002

1261

5.50

307.65

1.8

1.6

—

(3026782) Osmolality of Urine

3869

10031

3.13

307.65

4.2

2.4

490.74

558.72

mosm/kgh2o

65.06

3530

8774

(3013650) Neutrophils [#/volume] in Blood by Automated count

8851

34978

2.98

307.65

13.4

10.4

4.80

3.78

e9/l

216.06

7914

30116

(3035350) Ketones [Presence] in Urine by Test strip

7243

30601

2.20

307.65

5.7

3.1

5.68

5.42

estimate

0.04

1908

5902

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1625

2032

5.79

307.65

6.1

2.3

1.37

1.33

0.54

1615

2022

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1157

1393

5.82

307.65

4.4

2.5

3.66

3.55

g/l

1.22

1120

1332

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

7609

18466

5.00

307.65

7.4

2.3

92.09

29.10

ng/l

5.51

6591

11709

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1067

1604

4.61

307.65

4.7

2.1

88.83

95.12

11.45

1046

1541

(3022313) Gas panel - Capillary blood

1356

1985

4.83

307.65

7.1

3.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5936

15589

3.69

307.65

3.1

1.9

242.39

214.11

u/l

0.94

5682

14728

(3018418) pH of Serum or Plasma

5766

16776

3.20

307.65

8.4

3.5

7.40

4.08

4492

11528

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

9658

10325

20.35

307.65

7.1

1.8

2886.69

515.05

ng/l

171.69

9208

8332

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1370

125.62

307.65

3.2

2.1

0.84

0.80

nmol/l

0.30

1128

(3012516) Albumin [Mass/volume] in Urine

6082

9668

6.76

307.65

4.7

2.7

110.53

21.52

mg/l

68.99

4614

4898

(3037522) Nuclear Ab [Titer] in Serum

2641

7888

2.47

306.38

1.4

1.3

499.26

509.15

titre

0.09

565

1592

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

720

899

5.44

300.45

1.9

1.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

534

477

7.53

299.70

1.5

1.4

40040.34

54237.14

e6/l

0.47

314

284

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

488

389

8.42

298.07

1.4

1.2

329.25

746.04

u/l

2.08

463

368

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

753

990

5.18

298.00

1.7

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1019

1743

4.03

297.01

2.3

2.6

10.23

10.37

g/l

0.32

935

1538

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1025

1767

4.00

295.73

2.4

2.7

0.56

1.05

g/l

3.21

891

1526

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

743

976

5.18

294.26

1.7

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2360

6825

2.52

291.40

2.2

1.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

885

1377

4.40

289.99

1.6

1.4

11.35

15.48

iu/ml

0.36

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

757

1029

5.01

289.06

2.0

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1070

1944

3.80

287.72

2.7

2.6

—

(40758558) Short blood count panel - Blood

4760

18626

2.04

284.46

10.0

6.7

—

(3047181) Lactate [Moles/volume] in Blood

833

1262

4.51

281.53

8.7

4.9

1.41

1.27

mmol/l

2.34

753

1095

(3022806) Fractional oxyhemoglobin in Capillary blood

501

448

7.51

280.81

2.3

1.5

89.03

90.00

2.02

493

440

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

702

916

5.20

279.77

2.0

1.2

141.72

145.64

au/ml

0.29

210

305

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1706

4253

2.84

279.48

7.6

3.4

1.21

1.23

mmol/l

29.76

1581

3590

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

718

966

5.05

277.03

1.7

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

851

1337

4.35

275.34

1.9

1.6

0.24

0.23

g/l

4.82

813

1280

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

556

578

6.48

275.20

1.8

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

4263

16191

2.05

273.94

5.9

3.3

0.00

estimate

0.15

1632

5413

(3036782) Glucose [Moles/volume] in Pleural fluid

477

414

7.72

273.52

1.5

1.3

7.22

5.50

mmol/l

19.30

455

376

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

740

1037

4.85

273.13

1.9

1.2

15.45

26.55

u/ml

0.63

(3024932) HLA-DR beta [Type]

278

21.42

272.92

1.1

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

10654

56008

2.26

272.63

6.8

4.4

2.07

1.92

mu/l

17.69

10067

51168

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

896

1480

4.15

272.50

2.3

2.4

0.03

0.04

g/l

0.32

803

1339

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

865

1399

4.23

270.03

1.9

1.6

1.18

1.16

g/l

1.11

827

1345

(3024471) HLA-A [Type]

280

20.17

269.27

1.0

—

(40768446) Kidney Pathology biopsy report

245

31.76

268.97

1.9

1.1

—

(3037756) Immunofixation for Serum or Plasma

716

988

4.92

268.71

1.5

2.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

859

1391

4.22

267.70

2.3

2.5

0.00

g/l

0.50

752

1233

(40768806) Pleura Pathology biopsy report

505

485

6.99

267.25

1.6

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

634

795

5.39

262.99

1.7

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

561

621

6.08

262.39

1.8

1.5

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

355

213

11.09

259.83

2.4

2.3

1548.44

277.68

14.59

348

213

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

674

911

5.01

258.53

1.5

1.2

286.25

246.54

u/ml

2.33

477

570

(3002179) Metamyelocytes/Leukocytes in Blood

1818

4923

2.62

253.49

5.3

4.5

0.79

0.78

0.04

742

1537

(3017181) Myelocytes/Leukocytes in Blood

1884

5210

2.57

251.87

5.7

4.6

1.00

1.05

0.30

772

1617

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

682

960

4.81

250.17

1.6

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

682

960

4.81

250.17

1.6

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

804

1311

4.18

248.06

2.3

2.5

0.00

g/l

-0.00

752

1231

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1621

4185

2.73

247.33

4.2

2.4

50.70

76.65

ml/min/173m2

102.98

862

1481

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

573

690

5.59

247.30

1.2

1.4

39.32

43.87

u/l

0.25

517

597

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

10875

58426

2.23

245.23

10.1

4.1

43.83

37.32

mmol/mol

307.65

10349

54079

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

11429

62928

2.41

237.60

41.8

11.8

25.65

25.77

mg/l

0.15

10865

48498

(46235355) HIV 1 and 2 tests - Meaningful Use set

2561

8368

2.23

236.26

2.3

1.7

—

(3025159) Blasts/Leukocytes in Blood

1794

5022

2.53

232.77

5.9

4.9

0.16

0.36

1.13

652

1311

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

756

1245

4.12

230.07

1.7

1.4

—

(3021440) Promyelocytes/Leukocytes in Blood

1775

4994

2.51

227.60

5.7

4.7

0.09

0.13

1.55

665

1405

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6232

28210

1.83

225.96

3.3

2.2

73.86

3279.73

nmol/l

0.50

5701

25626

(3004451) EKG impression Narrative

281

143

13.01

224.55

1.4

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

619

882

4.73

223.69

1.2

255.43

250.00

titre

0.02

(44806118) Parainfluenza type 4 nucleic acid detection

510

605

5.65

223.15

1.7

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

510

605

5.65

223.15

1.7

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

510

605

5.65

223.15

1.7

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

974

1971

3.39

222.99

2.6

1.9

—

(44790047) Parainfluenza type 1 nucleic acid detection

510

606

5.64

222.79

1.7

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

3550

13439

1.98

221.20

5.0

3.0

0.40

0.17

0.74

120

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

915

1785

3.50

221.13

2.4

1.7

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

615

881

4.71

220.88

1.2

46.67

160.00

titre

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

451

477

6.32

219.49

2.3

2.6

23.72

24.23

iu/ml

0.03

(3040151) Glucose [Moles/volume] in Capillary blood

428

6.68

218.69

8.5

3.0

7.47

7.01

mmol/l

1.26

379

364

(3011985) Renin [Units/volume] in Plasma

381

332

7.64

217.53

1.4

1.8

99.72

64.14

mu/l

0.60

337

304

(21494890) Protein electrophoresis panel - 24 hour Urine

406

388

6.98

215.44

1.8

2.8

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1603

4405

2.55

214.92

3.6

2.1

0.65

0.34

e6/l

3.66

1555

4196

(3022493) Free Hemoglobin [Mass/volume] in Plasma

290

173

11.11

212.82

20.0

1.3

830.47

3841.41

mg/l

0.71

245

111

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1903

5699

2.37

212.59

3.3

2.4

36.04

57.74

u/l

0.81

1614

4922

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

439

467

6.28

212.52

1.2

1.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

11560

64710

2.37

212.16

54.6

11.5

139.06

139.97

mmol/l

219.87

11458

62886

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

362

309

7.79

209.91

1.4

1.2

11.31

16.72

u/l

2.23

308

290

(3023103) Potassium [Moles/volume] in Serum or Plasma

11565

64858

2.35

208.51

55.2

11.6

4.06

3.97

mmol/l

214.49

11455

62838

(3045716) Anion gap in Serum or Plasma by calculation

407

6.67

207.90

5.1

2.8

10.69

10.48

mmol/l

0.37

402

400

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

343

284

8.02

203.43

1.3

333.84

412.99

pmol/l

0.33

282

244

(3000012) Reticulocyte production index

499

638

5.24

202.42

2.5

2.7

1.00

0.85

4.57

400

438

(3003129) Base excess in Capillary blood by calculation

418

461

6.05

195.76

3.5

1.9

1.16

0.90

mmol/l

0.48

396

442

(3017569) Oxygen content in Arterial blood

283

188

9.97

194.77

2.4

2.3

15.60

16.06

0.86

283

188

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

538

765

4.72

194.59

1.3

1.4

14.10

17.06

u/ml

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5200

23094

1.77

190.35

5.7

3.0

0.21

0.50

estimate

0.65

1585

4632

(44816559) Phosphatidylethanol [Mass/volume] in Blood

920

1991

3.15

188.93

1.8

1.6

0.37

0.31

mg/l

1.89

491

955

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1492

4228

2.46

186.28

1.6

1.5

—

(3004775) Volume in Urine collected for unspecified duration

251

147

11.28

186.07

2.7

1.8

732.26

660.92

0.91

182

100

(3039000) Anion gap in Blood by calculation

560

864

4.35

184.14

10.3

6.1

11.62

11.02

mmol/l

2.57

520

764

(3018572) Chloride [Moles/volume] in Blood

560

864

4.35

184.14

10.3

6.1

103.90

105.18

mmol/l

5.45

520

764

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

521

768

4.54

180.75

3.6

1.5

1.07

0.69

nmol/l

14.24

409

660

(3034770) Mitochondria Ab [Titer] in Serum

732

1412

3.51

179.08

1.2

1.3

1010.00

938.27

titre

0.10

(3048929) Epstein Barr virus Ab [Presence] in Serum

752

1479

3.44

178.81

1.5

1.2

—

(3035880) pH of Pleural fluid

275

201

9.05

177.94

1.4

1.2

7.43

7.36

2.52

196

133

(3007566) Smooth muscle Ab [Titer] in Serum

727

1434

3.43

172.00

1.2

1.3

94.44

180.08

titre

0.95

122

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

339

349

6.45

168.74

1.8

1.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

327

324

6.69

168.21

1.6

1.3

14.02

11.27

u/l

6.22

310

311

(3037121) Protein [Mass/volume] in Urine

780

1658

3.18

164.35

4.2

3.1

578.48

347.70

mg/l

1.08

455

723

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

297

270

7.28

163.92

1.3

1.4

1.79

1.19

nmol/l

8.13

263

245

(3000494) Fungus identified in Specimen by Culture

2197

7698

2.02

163.36

1.9

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2991

11720

1.85

159.84

3.2

3.3

2.47

2.44

mmol/l

23.93

2638

10604

(3038071) Oxygen [Partial pressure] in Mixed venous blood

155

24.23

158.48

10.1

5.3

5.71

5.08

kpa

1.74

155

(3052851) Hemolysis interference index of Serum or Plasma

683

1364

3.37

158.42

5.3

2.6

3.07

2.38

index

0.74

415

631

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

762

1634

3.15

158.21

1.5

1.2

—

(40761536) Microorganisms panel - Urine sediment

1399

4166

2.32

155.28

6.4

3.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

2953

11621

1.84

155.00

1.8

1.5

2.93

2.41

g/l

21.13

1990

6993

(3016750) Collection duration of Urine

199

108

12.13

153.74

2.7

1.7

482.66

502.21

min

0.92

153

(3044242) Glucose [Moles/volume] in Arterial blood

252

202

8.24

152.92

2.4

1.9

8.72

7.53

mmol/l

3.11

252

202

(3008037) Lactate [Moles/volume] in Venous blood

574

1073

3.59

146.51

5.1

2.2

1.59

1.49

mmol/l

1.37

556

1049

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

10749

60643

1.84

145.17

6.8

3.9

6.56

5.66

mmol/l

307.65

9990

55580

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

212

142

9.83

145.10

1.2

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

435

8769

0.30

143.08

2.0

3.74

3.55

ratio

1.81

361

6909

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

305

338

5.97

142.04

1.4

1.1

87.61

81.95

0.75

(40768797) Stomach Pathology biopsy report

2239

8257

1.92

141.99

1.3

1.2

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

199

125

10.48

141.63

1.6

1.2

65.27

60.31

0.67

157

100

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

10557

59422

1.79

139.91

5.8

3.5

1.48

1.20

mmol/l

211.69

9856

54576

(3006576) Bicarbonate [Moles/volume] in Blood

167

14.25

139.86

8.0

4.0

25.40

25.58

mmol/l

0.10

153

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

484

830

3.89

138.97

1.4

1.2

5.04

3.35

u/ml

1.12

251

391

(3023419) Bacteria identified in Sputum by Culture

441

708

4.15

137.80

2.2

2.9

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1368

4249

2.22

136.79

1.6

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

481

849

3.78

132.84

1.4

1.2

4.84

3.34

u/ml

0.60

187

323

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

184

113

10.71

132.70

1.2

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

8208

43513

1.60

132.03

5.1

2.8

80.97

43.09

u/l

132.97

7780

40961

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

336

448

4.97

130.13

1.3

0.16

0.42

nmol/l

0.95

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

328

436

4.98

127.44

1.3

3.90

0.57

nmol/l

0.52

313

419

(3042631) Mycobacterium sp identified in Specimen

430

721

3.97

127.08

2.5

—

(3017732) Neutrophils [#/volume] in Blood

2036

7605

1.87

122.50

3.7

3.2

5.25

4.11

e9/l

5.61

1769

6512

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

211

185

7.51

119.76

2.4

1.9

186.20

150.61

4.24

200

172

(3023420) DNA double strand Ab [Units/volume] in Serum

848

2252

2.54

119.10

2.0

1.7

7.59

6.63

iu/ml

0.42

208

514

(3000093) Morphology [Interpretation] in Blood Narrative

319

441

4.79

118.75

1.2

1.1

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

281

6505

0.26

117.31

1.7

3.28

3.70

mmol/l

5.33

208

4548

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

634

1453

2.93

117.25

1.5

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

320

450

4.71

116.88

1.9

1.4

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

162

100

10.64

116.48

1.6

1.2

2.44

4.46

1.17

134

(3045414) Leukocytes [Presence] in Urine

1498

5130

2.01

115.53

2.8

1.9

0.02

0.03

estimate

0.42

304

1100

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

288

373

5.10

115.00

1.3

—

nmol/l

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

384

640

3.98

114.32

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

291

384

5.01

113.93

1.3

0.27

0.20

nmol/l

0.48

221

306

(40757494) Bilirubin.total [Moles/volume] in Blood

186

148

8.26

113.46

2.5

2.1

20.65

24.44

umol/l

0.19

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

10795

62217

1.72

112.15

39.9

11.0

70.28

83.82

ml/min/173m2

307.65

10456

56048

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

351

556

4.18

111.43

1.2

62.44

66.42

u/l

0.27

315

479

(21494755) Public health laboratory ask at order entry panel

388

7320

0.32

109.85

1.3

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

3679

16659

1.60

109.62

5.2

2.7

0.37

0.33

estimate

0.05

1501

4518

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

555

1230

3.01

108.58

1.4

1.2

—

(3012565) Volume of 24 hour Urine

190

166

7.52

108.14

2.5

2.6

1741.29

2039.69

2.15

172

154

(4195642) Thrombophilia screening test

431

815

3.52

107.96

1.4

1.2

—

(3044927) Protein electrophoresis panel - Urine

294

413

4.70

107.50

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1870

7064

1.84

107.40

2.0

1.7

1.70

1.41

34.31

1571

6326

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

431

818

3.50

107.38

1.3

1.1

100.39

118.65

15.51

411

740

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

168

127

8.69

106.22

2.7

2.6

0.61

0.63

mmol/l

2.24

168

127

(3014051) Protein [Presence] in Urine by Test strip

3684

16806

1.59

105.63

4.1

2.4

0.17

0.04

1.20

338

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

260

336

5.10

104.06

1.8

1.4

—

(3019150) Specific gravity of Urine by Refractometry

2993

13016

1.64

104.03

5.8

3.2

1.02

kg/l

0.87

2145

8428

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

371

648

3.80

103.80

1.4

1.1

92.36

98.11

2.72

358

602

(3016038) Potassium [Moles/volume] in Urine

210

220

6.28

102.89

1.2

1.3

33.38

35.90

mmol/l

0.57

187

196

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

245

304

5.31

102.25

1.8

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

301

454

4.38

101.39

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

301

454

4.38

101.39

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

301

454

4.38

101.39

1.8

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

314

491

4.23

101.26

1.1

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

239

296

5.32

99.93

1.8

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

458

957

3.18

98.56

1.6

1.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

426

855

3.31

97.61

1.3

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

154

117

8.63

97.05

1.5

1.1

16.72

13.79

g/l

2.08

131

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

121

132.12

96.69

5.7

1.2

710.08

—

iu/ml

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

196

206

6.26

95.76

1.2

1.1

3.17

3.31

iu/ml

0.09

(3038515) Glucose [Moles/volume] in Venous blood

441

917

3.20

95.63

5.6

2.3

7.92

6.94

mmol/l

8.14

423

901

(3000919) Neutrophils/Leukocytes in Pleural fluid

138

9.94

95.38

1.6

1.2

20.29

25.04

0.70

121

(3008295) Osmolality of Serum or Plasma

298

470

4.19

95.09

1.4

1.5

276.82

281.35

mosm/kgh2o

1.65

232

369

(4268621) Lupus anticoagulant assay

341

602

3.75

94.01

2.7

2.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

325

556

3.87

93.46

1.8

2.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

338

598

3.74

92.91

1.8

1.9

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

214

257

5.48

92.29

1.3

1.2

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

21.71

91.96

5.6

3.3

52.85

30.99

ug/min

2.33

(3004809) Band form neutrophils/Leukocytes in Blood

456

1001

3.03

90.52

4.1

3.6

1.39

1.95

2.17

416

898

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

20.26

89.87

7.6

5.9

10.60

10.83

0.18

(3023487) Leukocytes [#/volume] in Peritoneal fluid

185

196

6.20

89.76

2.4

1.6

1517.55

3861.60

e6/l

0.43

139

115

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

132

9.61

89.36

2.0

1.9

114.88

11.93

ug/min

1.66

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

609

1582

2.57

88.94

1.5

1.3

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

17.93

88.74

2.8

2.4

72.22

19.23

mg/l

1.07

(3000475) Leukocytes [#/volume] in Synovial fluid

561

1402

2.67

88.34

1.7

1.6

17394.40

12579.13

e6/l

0.92

386

983

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

10966

64463

1.64

88.18

7.5

4.6

2.27

3.05

mmol/l

307.65

10353

59654

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

207

254

5.36

87.38

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

207

254

5.36

87.38

1.5

—

(3019225) pH of Specimen

1527

5749

1.82

87.33

8.8

3.5

7.37

7.36

1.97

1296

3911

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

291

492

3.90

85.00

4.1

2.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

426

933

3.03

84.86

1.1

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

100

14.53

84.68

1.5

1.3

12.63

10.00

0.31

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

166

169

6.45

83.43

2.1

1.5

27853.91

8603.38

e6/l

0.84

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

248

375

4.36

83.30

1.2

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

10818

63629

1.60

82.51

6.6

4.2

4.08

5.04

mmol/l

307.65

10221

59185

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

10750

63235

1.58

80.29

6.6

4.1

1.28

1.56

mmol/l

307.65

10114

58606

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

13.94

79.78

1.4

5.65

981589.12

nmol/l

1.08

(3002331) Protein [Mass/volume] in Peritoneal fluid

133

109

7.99

79.45

1.5

1.3

151.41

25.70

g/l

0.51

111

(3051611) Lipemic interference index of Serum or Plasma

283

493

3.79

79.44

6.2

2.7

13.35

13.11

index

0.13

214

261

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

13.80

78.56

7.7

10.6

69.08

61.77

0.65

(3023383) Lactate [Moles/volume] in Pleural fluid

144

134

7.04

78.03

1.4

1.2

2.84

4.25

mmol/l

2.93

125

123

(3047189) Immunofixation for 24 hour Urine

174

201

5.68

77.96

1.6

2.3

—

(4146454) Self-monitoring of blood glucose

228

340

4.41

77.86

2.8

2.6

—

(3003694) ABO and Rh group [Type] in Blood

3675

17687

1.49

77.49

1.5

1.3

—

(3025941) Bacteria identified in Stool by Culture

918

3044

2.03

75.95

1.4

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

215

313

4.52

75.52

1.2

1.3

129.81

105.64

u/l

1.18

191

266

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

360

767

3.10

75.02

1.1

1.65

1.49

g/l

7.54

335

691

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1562

6196

1.72

74.05

14.6

4.4

—

(3045424) Erythrocytes [Presence] in Urine

831

2681

2.08

73.90

2.9

1.9

0.36

0.30

estimate

0.06

225

880

(3000570) Elastase.pancreatic [Mass/mass] in Stool

618

1765

2.34

73.75

1.5

1.4

245.27

271.21

ug/g

2.23

397

1046

(3020564) Creatinine [Moles/volume] in Serum or Plasma

11576

69654

1.68

73.65

53.8

13.9

101.24

73.27

umol/l

307.65

11483

68596

(3041918) Cholesterol [Moles/volume] in Pleural fluid

108

9.68

73.53

1.3

1.2

1.11

2.10

mmol/l

7.07

(3017704) Immunofixation for Urine

181

233

5.10

72.79

1.5

2.3

—

(3044007) Cell count panel - Peritoneal fluid

153

170

5.90

71.13

2.4

1.6

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

165

199

5.44

70.91

1.4

1.6

1.43

1.17

nmol/l

1.35

113

156

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

207

309

4.40

70.63

1.2

1.3

39.62

24.95

u/l

1.93

180

255

(3029634) Reagin Ab [Titer] in Serum by VDRL

355

781

3.01

70.16

2.3

2.8

11.50

7.31

titre

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

16.43

69.68

1.3

1.1

0.09

1.48

u/ml

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

481

1254

2.55

69.60

1.8

1.9

6.21

4.12

iu/l

0.40

161

471

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11436

68799

1.63

69.10

22.2

9.9

29.11

25.79

u/l

8.21

11253

66528

(3005322) IgE [Units/volume] in Serum or Plasma

1041

3729

1.88

68.80

1.4

1.3

320.80

224.65

u/ml

1.16

970

3454

(3024891) Influenza virus A+B Ag [Presence] in Specimen

539

1499

2.39

68.14

1.3

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

10.28

67.90

1.3

1.2

73.79

121.27

ng/l

0.41

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

242

424

3.76

67.43

1.2

240.80

182.25

titre

0.29

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

241

424

3.74

66.78

1.2

230.00

73.08

titre

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

117

102

7.50

66.77

1.5

1.2

27.52

20.90

1.00

(3002079) Sodium [Moles/time] in 24 hour Urine

108

8.31

66.46

1.2

1.3

165.64

147.25

mmol/24h

0.84

108

(3034426) Prothrombin time (PT)

145

164

5.79

66.32

1.5

1.1

30.31

27.16

5.69

145

164

(3014891) Appearance of Pleural fluid

11.60

65.91

1.8

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

401

980

2.71

65.76

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

168

223

4.94

65.43

3.0

2.6

149.85

36.95

mg/l

1.66

129

134

(3042010) Triglyceride [Moles/volume] in Pleural fluid

10.19

64.71

1.4

1.2

1.67

1.73

mmol/l

0.02

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

124

122

6.65

64.22

1.3

35.48

388.37

ug/l

1.35

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

12.04

64.17

1.3

1.2

45.66

813.90

u/l

0.60

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2832

13355

1.48

63.84

1.4

1.3

1.89

1.96

u/ml

0.07

719

3600

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

9266

53664

1.41

63.70

48.6

14.5

14.59

13.49

307.65

9197

52817

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

302

643

3.10

63.01

1.1

53.98

17209.93

iu/ml

0.53

136

(3009871) Measles virus Ab [Titer] in Serum

172

249

4.53

60.86

1.3

1.7

4036.92

3035.10

titre

0.48

(3015171) Extractable nuclear Ab [Units/volume] in Serum

662

2108

2.09

60.69

1.3

1.2

2.29

1.16

u/ml

0.65

153

(3020191) Ethanol [Moles/volume] in Serum or Plasma

234

437

3.52

59.68

1.8

1.5

1.20

1.46

promille

1.60

182

340

(3044941) Cell count panel - Synovial fluid

394

1005

2.59

59.51

1.5

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

195

319

4.01

59.51

1.5

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

142

177

5.25

59.09

1.6

2.2

67.75

132.78

umol/l

2.67

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

193

315

4.02

59.07

1.5

1.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

8.04

57.77

1.5

1.1

77.64

88.11

0.85

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

192

318

3.96

57.68

2.2

1.9

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

28.78

56.81

14.7

3.6

107.49

104.50

g/l

0.22

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

248

500

3.26

56.44

1.1

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

272

582

3.08

56.32

3.4

4.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

110

6.54

56.22

1.1

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

7.86

56.21

1.5

1.1

74.62

73.50

0.08

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

2752

0.22

55.93

1.2

1.1

0.65

ratio

0.00

397

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

25.14

55.82

1.4

1.2

93.22

89.69

ug/l

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

12.69

55.62

1.2

1.1

17.34

23.68

u/l

1.04

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

119

132

5.90

55.47

1.7

6.77

2.49

nmol/l

1.11

102

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

119

132

5.90

55.47

6.4

2.5

9.55

10.50

kpa

1.91

119

132

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

119

132

5.90

55.47

6.4

2.4

5.08

4.99

kpa

0.22

119

132

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

482

1406

2.27

54.69

1.3

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

482

1412

2.26

54.15

1.3

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

385

1018

2.50

54.10

1.5

1.6

0.76

0.87

g/l

0.61

297

806

(3049717) Cytology report of Urine Cyto stain

632

2067

2.03

53.91

2.5

2.9

—

(42529406) Shigella sp [Presence] in Stool by Culture

483

1420

2.25

53.81

1.3

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

162

248

4.28

53.71

3.4

3.8

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

278

626

2.92

52.84

1.6

67.46

56.32

4.22

186

399

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1136

4518

1.69

52.38

1.4

1.5

—

5.60

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

101

100

6.60

52.08

1.3

1.1

20.22

5.95

pmol/l

2.63

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

591

1915

2.05

51.67

1.6

12.42

2.89

iu/ml

0.42

113

360

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

198

365

3.56

51.49

1.0

1.1

306.76

287.19

mg/l

2.55

180

330

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

487

1471

2.19

50.87

1.3

1.2

24.82

11.87

u/ml

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

6830

38335

1.33

50.69

3.1

2.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1661

7315

1.54

50.50

3.4

4.9

13.23

34.17

ug/l

3.96

1395

5931

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

318

796

2.63

49.85

2.3

2.7

40.81

775.95

u/ml

1.16

309

790

(4035726) Immunohistochemistry procedure

1501

6490

1.57

49.42

1.8

1.4

—

(3000330) Specific gravity of Urine by Test strip

740

2644

1.87

48.86

4.6

2.8

1.02

ratio

0.15

678

2411

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

146

222

4.31

48.84

2.0

1.5

16695.81

3596.92

u/ml

0.36

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

133

2897

0.29

48.20

1.2

1.1

1.45

1.53

g/l

2.70

133

2897

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

169

301

3.68

46.15

1.2

1.1

43.05

20.42

u/l

3.13

152

262

(1761868) Lipid panel - Serum or Plasma

3357

27057

0.74

45.38

4.2

2.7

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

168

302

3.65

45.31

1.2

1.1

109.86

76.10

u/l

2.66

151

267

(3037692) Legionella sp identified in Specimen by Organism specific culture

136

208

4.28

45.20

1.7

1.1

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

11.05

45.06

1.6

1.3

66.67

82.00

1.89

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

769

2868

1.79

44.19

2.5

2.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

307

803

2.52

44.14

1.1

—

(44786800) Granulocytes/Leukocytes in Body fluid

8.97

42.93

1.3

1.2

18.96

32.50

1.37

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

142

235

3.95

42.80

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

142

235

3.95

42.80

1.5

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

252

606

2.73

42.66

1.5

1.3

2.64

3.03

g/l

2.39

182

445

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2318

11245

1.41

42.55

1.3

35.74

39.89

iu/ml

0.42

736

3506

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4559

24579

1.31

42.28

4.6

5.0

2.73

3.37

ug/l

1.00

4069

22660

(3027135) IgG subclass 1 [Mass/volume] in Serum

251

606

2.72

42.18

1.5

1.3

7.36

6.84

g/l

0.81

180

445

(3024139) IgG subclass 3 [Mass/volume] in Serum

251

606

2.72

42.18

1.5

1.3

0.50

0.44

g/l

0.37

181

442

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

+∞

42.01

13.9

0.0

127.00

—

e6/l

—

(4062490) Immunoglobulin typing, IgG

247

598

2.71

41.30

1.5

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

127

198

4.19

41.27

2.5

2.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

174

343

3.32

41.09

1.4

1.6

19.89

19.28

u/ml

0.04

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

349

1005

2.29

40.80

1.1

1.2

—

0.92

—

(3017354) Segmented neutrophils/Leukocytes in Blood

258

644

2.63

40.72

3.5

3.9

60.26

54.21

3.77

227

556

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

102

134

4.97

40.30

1.2

1.1

90.37

106.04

2.05

126

(3045142) Bone marrow Pathology biopsy report

293

785

2.46

40.11

1.3

1.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

438

1394

2.08

40.11

1.3

1.2

8.34

3.59

u/ml

0.37

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

166

325

3.35

39.62

1.5

10.29

5.69

u/l

1.83

125

245

(4024509) Urine culture

670

2477

1.80

39.57

2.4

1.7

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

6.01

39.08

1.5

1.3

76.72

658.43

nmol/24h

0.87

(21491868) Cryoglobulin [Mass/volume] in Serum

114

171

4.36

38.84

1.3

1.2

0.14

0.37

g/l

0.50

(21494434) Karyotype in Bone marrow

228

547

2.74

38.80

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

161

319

3.30

37.76

1.3

184.55

65.83

titre

0.50

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

135

4.79

37.60

1.1

75.87

92.81

3.72

(3010838) Calcium [Moles/time] in 24 hour Urine

333

976

2.25

37.40

1.8

2.2

4.10

5.60

mmol/24h

11.25

299

863

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

8.79

37.26

1.3

2.8

0.87

1.75

mmol/l

1.48

(3022145) Colonoscopy Study observation

1640

7639

1.45

37.13

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

6.35

37.06

1.7

1.3

0.15

0.33

mmol/l

0.84

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

160

320

3.27

37.00

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

160

320

3.27

37.00

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

160

320

3.27

37.00

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

160

320

3.27

37.00

2.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

163

330

3.23

36.99

1.3

971.43

120.00

titre

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

132

4.80

36.93

1.1

73.68

91.96

3.00

(3009466) Valproate [Moles/volume] in Serum or Plasma

293

819

2.35

36.65

5.6

5.3

357.01

363.42

umol/l

0.32

270

699

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

217

525

2.71

36.38

2.1

1.9

5.51

3.09

mg/l

7.32

208

508

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

+∞

35.88

5.9

0.0

426.63

—

umol/l

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

507

1774

1.89

35.59

1.3

1.2

30.60

39.57

u/ml

0.30

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

263

710

2.43

35.48

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

266

722

2.42

35.47

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

479

1652

1.92

35.11

1.3

3.72

3.71

u/ml

0.00

144

(3024522) Salmonella sp identified in Specimen by Organism specific culture

262

713

2.41

34.75

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

478

1654

1.91

34.70

1.4

1.3

7.91

6.37

u/ml

0.25

220

(3010144) Erythrocytes [#/volume] in Synovial fluid

210

514

2.68

34.47

1.4

137283.30

75991.59

e6/l

0.48

127

342

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

5.53

34.42

1.6

1.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

196

463

2.77

34.36

1.1

—

(3007461) Platelets [#/volume] in Blood

11577

71632

1.43

34.04

58.9

17.4

239.92

249.00

e9/l

34.87

11415

69629

(3005988) Vibrio sp identified in Specimen by Organism specific culture

253

686

2.42

33.83

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

252

686

2.41

33.42

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

251

683

2.41

33.32

1.5

—

(3035941) MCH [Entitic mass]

11577

71679

1.42

33.24

58.6

17.3

30.29

30.44

13.78

11488

70691

(3024731) MCV [Entitic mean volume] in Red Blood Cells

11577

71684

1.42

33.16

58.7

17.3

92.15

91.25

68.70

11488

70690

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

11577

71689

1.42

33.08

61.7

17.6

39.09

41.98

30.42

11486

70636

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

302

895

2.22

33.08

1.7

2.2

21.71

25.18

ug/l

0.75

293

881

(3026361) Erythrocytes [#/volume] in Blood

11577

71691

1.42

33.04

58.8

17.3

4.32

4.55

e12/l

298.39

11390

69413

(3010813) Leukocytes [#/volume] in Blood

11578

71704

1.42

32.95

58.9

17.4

7.54

6.31

e9/l

307.65

11391

69409

(3000963) Hemoglobin [Mass/volume] in Blood

11578

71710

1.42

32.85

59.5

17.4

129.14

137.76

g/l

307.65

11498

70724

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

+∞

32.38

10.6

0.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

192

471

2.67

31.42

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

205

2989

0.44

30.80

1.6

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

113

207

3.57

29.83

1.2

1.1

3.45

2.62

u/ml

0.30

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

+∞

29.75

4.5

0.0

1.47

—

g/l

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

223

606

2.41

29.73

1.2

25.00

41.23

u/ml

0.44

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

117

4.57

29.69

1.4

1.5

20.51

13.85

pmol/l

2.02

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

8.50

29.56

2.8

1.3

62.39

58.83

0.18

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

11.78

29.10

1.2

1.0

—

(3011412) CD3 cells [#/volume] in Blood

224

617

2.38

29.02

2.4

2.6

938.41

1224.70

e6/l

1.07

201

546

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

+∞

28.88

9.9

0.0

45.68

—

(36660697) Celiac disease serology panel - Serum

1055

4728

1.49

28.70

1.2

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

190

488

2.55

28.48

1.6

20.17

32.92

6.15

129

304

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

7.22

28.47

1.1

790.74

359.39

pmol/l

0.62

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2052

10360

1.34

28.13

1.3

13.56

12.89

u/ml

0.08

726

3989

(40757373) Influenza virus identified in Isolate

5.02

28.07

1.8

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

140

307

2.98

28.04

1.2

1.3

11.10

7.87

mmol/l

9.44

122

288

(3002621) Streptococcal DNAse B [Units/volume] in Serum

7.24

27.96

1.0

197.63

467.91

u/ml

—

(3014271) Vancomycin [Susceptibility]

110

210

3.42

27.40

3.5

2.9

—

(3022621) pH of Urine by Test strip

1002

4486

1.49

27.35

3.6

2.2

5.93

6.07

4.69

749

2933

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

180

464

2.54

26.81

2.0

2.2

14.98

16.39

0.90

174

456

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

186

491

2.48

26.41

1.4

1.2

90.15

119.20

pmol/l

10.77

186

491

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

121

252

3.14

26.40

4.6

3.0

0.97

1.27

1.05

121

252

(40768443) Skin Pathology biopsy report

689

2872

1.59

25.99

1.3

1.2

—

(1175426) CD3 cells/Lymphocytes in Blood

185

492

2.46

25.87

2.1

2.2

73.54

72.15

0.51

175

477

(3001964) Herpes simplex virus Ag [Presence] in Specimen

150

3.83

25.69

1.8

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

117

245

3.12

25.32

3.6

3.3

34.01

19.79

mu/l

2.15

105

229

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

9.63

25.26

2.4

1.1

15.48

42.11

—

(1761482) Bacteria [#/volume] in Urine by Culture

353

1229

1.89

25.22

5.4

3.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

243

739

2.16

25.10

1.3

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

222

651

2.23

25.03

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

126

279

2.95

24.88

1.1

1.09

1.06

ratio

1.72

114

223

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

154

384

2.62

24.53

2.0

1.8

1.41

8.28

u/field

0.55

203

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

132

306

2.82

24.08

1.1

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

234

713

2.15

24.07

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

768

3339

1.52

24.06

1.9

1.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

141

341

2.70

23.82

1.2

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

404

1497

1.78

23.70

3.0

3.9

1836.76

682.90

u/ml

0.33

352

1373

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

223

672

2.17

23.58

3.0

1.9

24.26

26.73

mg/l

0.30

232

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

5.21

23.43

2.2

1.1

1.17

1.16

mmol/l

0.37

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

5.81

23.26

1.0

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

262

851

2.02

22.86

1.2

29.78

8.10

u/ml

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

182

510

2.34

22.81

1.2

46.38

90.29

u/ml

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

11.48

22.66

7.5

2.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

103

214

3.14

22.62

2.0

2.9

38.09

40.98

g/l

4.13

103

214

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

5.00

22.45

1.9

1.6

7.51

6.94

mmol/l

0.54

(3033923) Metanephrine [Moles/time] in 24 hour Urine

7.02

22.44

1.1

1.2

0.85

0.71

umol/24h

0.47

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.69

22.09

2.4

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

40.30

21.85

4.2

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

617

2621

1.55

21.45

2.6

4.1

433.18

1300.36

u/ml

1.34

526

2258

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

8.13

21.39

1.1

1.0

12.78

3.40

iu/ml

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

388

1466

1.74

21.32

1.2

1.3

162.64

211.43

miu/ml

1.38

696

(37021550) Renin [Units/volume] in Plasma --upright

5.97

20.99

1.3

1.5

148.48

67.17

mu/l

0.98

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

984

8663

0.72

20.93

1.4

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

6.51

20.59

1.5

1.7

46.02

47.55

umol/l

0.11

(3039162) Centromere protein B Ab [Units/volume] in Serum

227

731

2.03

20.33

1.4

1.2

62.69

65.96

u/ml

0.05

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4706

27047

1.20

20.15

2.2

1.8

1.52

1.26

mmol/l

48.42

3965

22867

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

+∞

20.12

5.2

0.0

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

668

2931

1.51

20.03

1.1

62.19

3.31

u/ml

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

5.28

19.96

1.0

—

(3002256) Pathology report gross observation

1708

8789

1.30

19.87

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

111

3.87

19.70

1.3

1.4

140.00

737070.83

u/ml

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1519

7705

1.32

19.61

5.8

4.0

32.20

31.77

0.74

1188

4616

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

147

402

2.39

19.50

2.8

1.6

—

(3046861) Legionella sp Ag [Presence] in Urine

8.98

18.96

1.0

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

222

729

1.99

18.88

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

141

3.42

18.62

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

8.57

18.39

1.4

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

162

3.22

18.38

1.2

—

(3020491) Glucose [Moles/volume] in Blood

123

320

2.51

18.15

2.4

1.4

8.07

6.35

mmol/l

5.17

221

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

198

635

2.04

17.98

1.2

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

105

253

2.71

17.98

2.2

2.3

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

9.24

17.98

1.1

—

(3010503) CD19 cells [#/volume] in Blood

145

410

2.31

17.92

2.5

2.7

197.28

156.05

e6/l

0.20

137

401

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

149

427

2.28

17.86

2.4

2.7

441.59

589.14

e6/l

0.88

116

343

(3004716) Salmonella sp identified in Stool by Organism specific culture

580

2532

1.51

17.83

1.3

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

209

2.87

17.52

2.0

2.1

1.84

1.54

ratio

0.88

201

(3048689) Calprotectin [Mass/mass] in Stool

1508

7761

1.30

17.38

2.2

2.6

184.02

122.33

ug/g

6.27

1226

6172

(3038026) Centromere Ab [Units/volume] in Serum

149

434

2.24

17.22

1.2

36.04

39.68

u/ml

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

520

2235

1.53

17.19

1.6

29.33

21.80

u/ml

0.72

598

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

103

252

2.67

17.16

2.3

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

103

252

2.67

17.16

2.3

2.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

156

3.18

17.12

1.9

2.4

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

148

433

2.23

16.94

2.5

2.8

190.19

237.54

e6/l

1.42

131

368

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

8.36

16.83

1.3

1.4

0.53

1.33

ml/s/173m2

3.97

(3002619) Bacteria identified in Specimen by Culture

125

3.44

16.80

1.4

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

5.60

16.69

1.5

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

109

280

2.54

16.54

1.8

2.2

15.16

12.33

umol/l

0.26

215

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

176

558

2.06

16.52

1.5

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

9.75

16.52

1.0

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.51

16.50

2.5

1.9

—

(3028433) Virus identified in Specimen by Culture

181

2.95

16.44

1.3

1.2

—

(4281824) Cell count and differential, peritoneal fluid

209

711

1.92

16.15

1.4

1.1

—

(3024263) Appearance of Synovial fluid

107

276

2.53

16.12

1.8

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.31

16.09

2.3

1.9

—

(40768441) Liver Pathology biopsy report

148

443

2.18

16.07

1.7

1.2

—

(21494815) CD4 cells/Lymphocytes in Specimen

192

636

1.97

16.02

2.1

2.3

40.12

36.10

2.63

187

625

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

102

260

2.56

15.74

1.7

2.83

3.36

u/field

0.20

183

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

335

1324

1.66

15.73

1.3

1.2

65.52

40.33

u/ml

1.28

107

(3043410) Blood group antigens tested for on Red Blood Cells

141

3.19

15.69

1.8

1.5

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

29.91

15.43

3.5

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

258

959

1.76

15.12

1.8

1.5

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

155

3.03

15.08

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

155

3.03

15.08

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

155

3.03

15.08

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

155

3.03

15.08

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

136

404

2.20

15.07

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

121

343

2.30

14.95

2.0

1.3

114.21

77.43

umol/l

3.21

121

343

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

4.03

14.84

2.2

1.9

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

6.29

14.55

2.3

1.2

198.82

164.26

ug/g

0.32

(3036670) Protein [Mass/volume] in Synovial fluid

144

3.03

14.10

1.1

1.3

37.93

40.80

g/l

0.64

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

3.76

13.92

1.4

1.2

1.14

0.86

mg/l

0.43

(3019174) dRVVT (LA screen)

5.74

13.88

1.2

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

135

414

2.13

13.88

2.4

3.3

40.01

37.07

0.80

198

(3034891) Synovial lining cells/cells in Synovial fluid

259

2.44

13.69

1.5

1.6

2.61

4.17

0.51

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

103

283

2.37

13.68

1.1

1677.93

1522.14

miu/ml

0.70

103

283

(3017315) Amylase [Enzymatic activity/volume] in Urine

102

279

2.38

13.68

1.4

1.1

198.74

526.63

u/l

1.67

261

(40761539) Cells [Type] in Urine sediment by Light microscopy

107

3.35

13.53

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

5.57

13.52

1.2

—

(21494814) CD8 cells/Lymphocytes in Specimen

101

278

2.37

13.37

2.0

2.1

32.68

32.72

0.01

101

278

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

166

559

1.94

13.30

1.3

1.2

—

(4034850) Laboratory test

415

1801

1.51

13.19

21.9

6.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

378

1611

1.54

13.06

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

164

555

1.93

12.97

1.3

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

107

3.29

12.94

1.4

1.2

31.74

40.66

0.76

(4094501) Cardiovascular stress test using bicycle ergometer

341

1429

1.56

12.71

1.1

1.0

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

105

303

2.26

12.54

1.4

1.5

2469246.44

1341170.36

iu/ml

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

215

803

1.75

12.49

3.3

4.0

13.52

11.80

nmol/l

0.09

205

787

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.81

12.13

1.1

1.3

—

(40768804) Tissue Pathology biopsy report

4561

26933

1.15

12.13

2.3

2.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

219

2.47

12.06

2.2

2.3

61.26

47.48

umol/l

2.08

193

(3052592) Norovirus Ag [Presence] in Stool

3.53

12.00

1.4

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

144

480

1.96

11.93

2.1

2.8

0.57

0.70

e9/l

0.64

126

461

(4015189) Microbial culture of sputum

144

2.80

11.51

1.9

2.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

199

2137

0.60

11.33

1.5

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

514

4563

0.72

11.33

1.8

1.9

—

(3032057) Clostridioides difficile [Presence] in Stool

3.25

11.16

2.2

1.8

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

154

2.71

11.16

1.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.45

11.15

1.2

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

229

2.36

11.02

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

123

2.91

10.92

1.1

1.4

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

204

783

1.70

10.83

2.0

2.1

5600.00

2409.18

titre

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

145

505

1.87

10.62

1.2

—

(3006245) CD3-CD19+ cells/cells in Blood

222

2.35

10.51

2.1

2.4

12.34

9.48

0.60

210

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

126

2.84

10.49

1.0

1.1

1025.00

836.00

titre

0.57

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

119

395

1.96

10.06

1.8

2.4

16.66

17.61

nmol/l

0.62

112

377

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

219

2.32

10.00

1.1

1.3

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

224

2.30

9.92

2.1

2.3

30.16

29.14

0.20

216

(3001186) Copper [Moles/volume] in Serum or Plasma

165

2.53

9.83

1.2

17.01

15.64

umol/l

1.40

136

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

117

2.84

9.74

2.6

2.5

607.86

15.44

ug/l

0.54

117

(40759836) Histone Ab [Presence] in Serum by Immunoblot

140

497

1.84

9.71

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

211

2.32

9.60

1.0

102.45

96.51

0.60

169

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.56

9.51

1.3

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

103

332

2.02

9.47

1.9

1.3

7.10

5.94

u/l

0.33

289

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

759

0.40

9.38

1.6

1.3

145.16

187.28

pmol/l

1.45

759

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

150

2.56

9.33

1.8

1.7

10.18

9.09

ug/l

0.92

150

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

4.14

9.25

1.5

2.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

354

1608

1.44

9.09

1.1

4.26

3.90

0.12

247

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

132

473

1.82

8.93

1.4

1.2

2.30

2.12

mmol/l

0.58

123

450

(3050129) First trimester maternal screen panel - Serum or Plasma

403

0.21

8.90

1.8

1.4

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

227

2.21

8.89

2.4

2.7

144.59

144.72

nmol/l

0.00

194

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

196

788

1.62

8.82

1.8

2.4

593.83

4108.77

u/l

2.72

312

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.59

8.82

1.1

1.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

130

466

1.82

8.80

1.3

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3398

20006

1.14

8.77

3.8

3.9

22.33

20.69

6.61

1520

9166

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

116

402

1.88

8.72

1.2

1.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

5.61

8.66

1.0

1.1

2.30

1.45

umol/24h

1.73

(3020961) Endomysium IgA Ab [Titer] in Serum

561

2774

1.33

8.64

1.1

247.40

241.21

titre

0.01

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

177

2.35

8.55

1.6

0.46

0.36

ug/l

0.81

120

(3018333) Ribosomal P Ab [Presence] in Serum

127

457

1.81

8.50

1.3

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

460

2215

1.36

8.45

1.6

1.7

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

133

487

1.78

8.42

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

133

487

1.78

8.42

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

113

393

1.87

8.42

1.2

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

130

473

1.79

8.40

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

168

1740

0.62

8.33

2.1

2.2

—

(3006270) Folate [Moles/volume] in Blood

121

432

1.83

8.32

1.2

1.1

316.53

364.32

nmol/l

1.78

379

(3035320) C reactive protein [Mass/volume] in Body fluid

118

418

1.84

8.31

4.3

2.3

25.76

31.83

mg/l

1.17

288

(3009214) Lutropin [Units/volume] in Serum or Plasma

325

1479

1.44

8.30

1.4

10.61

9.75

u/l

0.46

255

1205

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

488

4159

0.75

8.24

1.7

1.9

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

208

2045

0.65

8.13

2.1

2.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

307

1.97

8.08

1.1

—

(44786798) Granulocytes/Leukocytes in Peritoneal dialysis fluid

+∞

7.87

2.8

0.0

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

289

1.96

7.46

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

285

1.97

7.43

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

128

2.49

7.43

1.2

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

3.51

7.27

1.1

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

311

1442

1.41

7.23

1.4

1.3

4.32

3.59

mmol/l

13.03

299

1359

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

167

2.26

7.15

1.1

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

347

1643

1.38

7.14

1.5

1.3

545.52

595.22

mg/l

0.61

334

1560

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

3.06

7.03

1.9

1.5

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.98

6.95

4.4

3.2

1.82

1.12

mg/l

0.84

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

717

3767

1.25

6.94

1.2

110.53

156.06

u/ml

2.78

247

1431

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

157

2.28

6.93

1.3

1.2

0.34

0.29

g/l

4.67

131

(37208534) Antinuclear antibody arbitrary concentration in serum

191

2.15

6.89

1.1

—

(3033099) Centromere Ab [Titer] in Serum

129

2.42

6.89

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

304

1417

1.40

6.88

1.4

61.87

24.78

e6/l

0.42

231

1043

(4198724) Urine methamphetamine measurement

196

2.13

6.84

1.6

1.8

—

(3011436) Histone Ab [Units/volume] in Serum

110

2.54

6.82

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

338

0.25

6.80

1.5

1.4

1.19

0.95

ratio

—

202

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

338

0.25

6.80

1.5

1.4

1.45

1.22

ratio

—

202

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

338

0.25

6.80

1.5

1.4

1.13

1.11

ratio

—

202

(3028717) Thiamine [Mass/volume] in Blood

3.05

6.80

1.3

1.1

64.61

62.18

ug/l

0.24

(3051387) C reactive protein [Mass/volume] in Capillary blood

272

1247

1.42

6.76

5.9

2.6

24.97

28.30

mg/l

0.87

216

819

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

336

0.25

6.74

1.5

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

122

468

1.70

6.68

1.4

2.25

2.00

u/ml

0.08

287

(3043238) Trisomy 21 risk [Likelihood] in Fetus

300

0.22

6.62

1.6

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

162

670

1.58

6.62

2.5

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

124

2.41

6.58

2.3

2.9

4623.39

911.36

u/l

0.90

111

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

305

1435

1.39

6.56

1.5

926.05

1649.21

e6/l

0.71

252

1116

(40768800) Prostate Pathology biopsy report

186

1784

0.67

6.51

1.2

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

286

1.89

6.47

1.2

57.00

73.75

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

203

889

1.49

6.42

1.1

2.80

3.22

0.20

153

(3017937) Magnesium [Moles/time] in 24 hour Urine

14.29

6.26

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

14.29

6.26

1.0

1.4

—

mmol/l

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

6.14

6.26

10.9

6.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

289

0.22

6.26

1.6

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

292

1384

1.38

6.04

1.8

340.38

281.72

mu/l

1.94

262

1283

(3013166) Neutrophils/Leukocytes in Synovial fluid

146

2.23

6.03

1.3

74.01

51.00

5.31

126

(40768795) Lymph node Pathology biopsy report

182

790

1.50

6.03

1.2

1.3

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

2.60

6.01

3.9

4.1

38.27

44.47

umol/l

0.79

(40762887) Creatinine [Moles/volume] in Blood

3.59

5.87

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

2.83

5.83

1.4

1.1

—

(4212803) Bone marrow aspirate examination

3.32

5.77

1.2

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

147

2.17

5.58

1.3

1.2

111.90

106.48

0.73

137

(3044290) Cell count panel - Cerebral spinal fluid

289

1390

1.36

5.50

1.6

1.4

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

171

0.19

5.47

1.0

1.2

85.16

71.12

u/ml

—

164

(40765096) Chromosome analysis panel by Banding

202

1.96

5.40

1.0

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.77

5.38

1.1

1.0

—

(3009015) Lactate [Moles/volume] in Synovial fluid

2.91

5.34

1.1

1.3

6.72

6.62

mmol/l

0.03

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.83

5.29

1.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

976

7350

0.85

5.26

2.7

2.1

11.54

15.14

nmol/l

37.59

848

6846

(4211845) Urine protein measurement

261

1.82

5.17

4.2

2.6

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.54

4.97

1.2

1.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

7.94

4.90

4.7

1.0

—

(3006462) Nitrate [Presence] in Urine

243

1.82

4.85

4.3

2.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

366

1857

1.29

4.84

1.3

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

311

1.72

4.80

1.7

7.71

8.92

ug/l

0.49

290

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

287

1.75

4.79

1.8

1.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

175

1.97

4.77

1.2

1.1

—

(3035082) Kappa light chains [Mass/volume] in Urine

5.63

4.65

1.1

1.2

0.02

0.57

g/l

—

(3026470) Cobalt [Mass/volume] in Blood

364

1.65

4.63

2.2

2.3

4.78

3.51

ug/l

0.36

334

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

298

0.35

4.62

1.4

1.6

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

2.97

4.48

2.0

1.0

25.96

19.44

mmol/l

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

3.75

4.47

3.9

13.50

9.92

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

122

2.13

4.45

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

173

1.92

4.29

1.8

2.2

0.16

0.41

e9/l

0.50

(3025577) Chromium [Mass/volume] in Blood

354

1.62

4.19

2.2

2.20

2.52

ug/l

0.34

303

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

3.01

4.17

1.6

1.1

13.00

22.93

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

139

2.01

4.15

1.0

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

5.20

4.11

1.3

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

118

2.09

4.07

1.2

1.1

—

(44806071) Cardiolipin IgM antibody measurement

2.44

4.07

1.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

293

1481

1.29

4.06

1.1

22.75

7.97

eliau/ml

0.72

212

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

145

1.97

4.04

1.0

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

303

1.65

4.01

1.5

1.7

2.03

1.88

umol/l

0.64

270

(3051101) Glucose [Moles/volume] in Cord blood

2.73

3.92

5.4

5.1

8.65

8.31

mmol/l

0.19

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

161

1.90

3.88

1.5

1.4

3.12

4.22

umol/l

1.30

141

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.07

3.85

1.1

1.0

0.13

0.02

u/ml

0.58

(3047007) Chlamydophila sp Ab [Presence] in Serum

192

921

1.36

3.85

1.2

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

857

0.65

3.82

1.1

5.33

4.00

u/ml

0.19

379

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.95

3.78

2.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

183

1587

0.75

3.70

1.4

1.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.71

3.70

1.5

1.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.35

3.65

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

203

1.76

3.63

3.1

3.3

1.80

1.54

ratio

0.33

183

(3014133) Dog dander IgE Ab [Units/volume] in Serum

901

0.67

3.62

1.1

5.10

2.64

u/ml

0.73

442

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

142

0.27

3.61

9.0

6.2

7.33

8.26

—

142

(40761995) Spermatozoa Progressive [#/volume] in Semen

142

0.27

3.61

4.5

3.1

27.67

43.41

—

142

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

4.02

3.60

1.1

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

147

1.90

3.60

1.0

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

161

1.86

3.59

1.1

—

(3045462) Protein/Creatinine [Ratio] in Urine

2.35

3.54

4.7

2.9

61.47

15.09

mg/mmol

0.85

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.35

3.54

1.0

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.78

3.50

1.6

1.5

0.59

1.20

mg/l

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

2.28

3.46

1.5

1.3

57.80

62.52

—

(3023410) Appearance of Cerebral spinal fluid

143

667

1.40

3.44

1.7

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

251

1.66

3.43

1.0

1.1

4.82

5.41

u/ml

0.09

(3004347) Hepatitis D virus Ab [Presence] in Serum

4.47

3.41

1.0

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

209

1.71

3.32

3.0

3.4

28.71

28.07

umol/l

0.17

161

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

403

1.50

3.30

1.6

1.8

525.42

322.20

mu/l

1.15

342

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.76

3.27

1.6

1.5

0.27

1.15

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.76

3.27

1.6

1.5

0.25

2.92

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

2.76

3.27

1.6

1.5

1.19

1.11

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.76

3.27

1.6

1.5

0.24

0.52

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.76

3.27

1.6

1.4

1.84

3.23

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.76

3.27

1.6

1.4

3.68

3.17

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.76

3.27

1.6

1.5

0.30

2.11

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.76

3.27

1.6

1.4

0.44

3.25

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.76

3.27

1.6

1.5

2.34

3.94

mg/l

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.66

3.24

1.2

1.4

1.01

1.70

iu/ml

0.98

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.34

3.22

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.23

3.16

1.4

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

782

0.67

3.15

1.0

1.1

0.18

0.22

u/ml

0.20

257

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

114

1.94

3.05

1.1

1.5

26.65

46.59

mg/l

2.28

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.74

3.04

1.1

1.4

0.54

0.43

iu/ml

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

189

1.69

2.85

1.3

1.4

138.44

140.30

nmol/l

0.02

131

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.02

2.84

1.4

1.8

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.98

2.80

1.3

1.6

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

4.18

2.73

1.0

1.1

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

4.18

2.73

1.0

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

4.18

2.73

1.1

1.0

0.04

0.03

u/ml

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

154

1.73

2.64

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

605

0.66

2.61

1.0

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

577

3273

1.15

2.61

3.2

4.1

83.69

67.15

u/ml

0.59

554

3172

(3023323) Follitropin [Units/volume] in Serum or Plasma

257

2035

0.82

2.58

1.5

1.4

24.82

35.92

iu/l

5.44

207

1722

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1398

9843

0.91

2.58

1.5

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

118

1025

0.75

2.54

1.1

0.91

1.49

u/ml

0.75

516

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.24

2.50

2.0

2.2

0.74

0.64

u/field

0.17

(3001729) Color of Synovial fluid

2.50

2.45

1.7

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

212

0.46

2.42

1.3

1.5

62.82

59.81

ug/l

0.07

212

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

4.00

2.39

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.96

2.37

1.0

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

262

0.52

2.36

1.7

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.04

2.33

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

160

0.41

2.23

1.4

1.2

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

8686

55343

1.06

2.21

51.1

14.4

328.30

332.92

g/l

319.79

8636

55033

(3018291) Platelet Ab [Presence] in Serum

4.13

2.21

1.1

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

2.12

0.0

1.1

—

0.17

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.46

2.12

1.1

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.08

2.07

1.0

1.2

238.44

245.26

nmol/l

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

127

1.69

2.02

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

137

1.66

2.02

1.0

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.41

2.01

1.2

1.5

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.79

2.01

2.3

1.9

13.77

18.56

umol/l

1.56

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

370

1.39

2.01

1.1

7.96

4.32

nmol/l

0.23

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

365

2730

0.86

1.98

1.9

1.8

38.71

44.13

nmol/l

4.89

353

2687

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

174

1.57

1.95

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

236

0.55

1.93

1.8

2.1

6.13

10.21

mg/l

2.23

195

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.44

1.90

1.1

1.0

6.34

6.08

mmol/l

0.51

(40762814) Titanium [Mass/volume] in Blood

110

1.71

1.88

2.4

2.6

3.44

3.35

ug/l

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.90

1.86

1.0

31.43

45.05

umol/24h

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

241

1317

1.19

1.84

1.5

1.4

352.04

153.87

pmol/l

1.41

232

1286

(3025130) Human papilloma virus identified in Specimen

810

0.77

1.78

2.1

1.8

—

(3003740) Influenza virus B Ag [Presence] in Specimen

143

1150

0.81

1.78

1.1

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.66

1.77

1.3

1.1

367.67

541.94

u/l

—

(3016135) IgD [Mass/volume] in Serum

3.54

1.73

5.2

2.0

39.22

170.47

mg/l

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

568

0.73

1.70

1.0

268.40

348.96

ng/l

2.51

435

(3002523) Influenza virus A Ag [Presence] in Specimen

144

1148

0.81

1.67

1.1

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

307

1.38

1.63

15.6

12.8

0.63

0.62

mmol/l

0.16

283

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.17

1.63

1.4

1.5

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.17

1.63

1.0

1.1

—

(44813793) Dust mix specific IgE antibody measurement

408

1.32

1.62

1.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

314

1.37

1.59

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

633

4508

0.91

1.58

1.3

39.89

53.46

au/ml

1.00

351

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

575

0.74

1.58

1.0

832.08

744.27

ng/l

0.70

424

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

575

0.74

1.58

1.0

36.66

43.75

ng/l

1.09

436

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.30

1.58

1.0

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

2.30

1.58

1.0

1.1

—

55.00

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

135

1075

0.81

1.57

1.0

1.1

0.91

1.10

u/ml

0.21

490

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.16

1.51

6.3

6.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

240

1.41

1.51

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.02

1.51

1.4

1.1

12.07

11.22

u/l

0.05

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.67

1.48

1.1

—

(3027944) Amphetamines [Presence] in Urine

248

1859

0.86

1.47

2.4

1.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

166

1283

0.84

1.44

1.1

1.70

1.63

u/ml

0.03

690

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.98

1.43

1.0

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.25

1.40

1.6

1.1

2.80

3.20

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.78

1.38

1.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

695

4891

0.92

1.37

2.4

23.91

22.23

au/ml

0.13

625

(3036071) Salmonella sp Ab [Titer] in Serum

185

1.44

1.37

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.25

1.36

1.0

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

123

652

1.23

1.36

1.1

—

5.98

—

(3006598) pH of Arterial cord blood

0.00

1.35

0.0

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

1.35

0.0

1.0

—

-3.65

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

142

1105

0.83

1.35

1.0

1.1

6.41

3.87

u/ml

0.68

591

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.87

1.34

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.87

1.34

1.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

114

0.51

1.33

1.2

2.5

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.47

1.32

1.1

1.0

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.78

1.31

1.3

1.6

0.11

0.16

nmol/l

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

113

597

1.23

1.30

1.3

1.4

30.60

34.22

u/l

0.50

499

(3012494) Peanut IgE Ab [Units/volume] in Serum

139

1.50

1.29

1.1

1.04

1.70

u/ml

0.31

(3014599) Egg white IgE Ab [Units/volume] in Serum

363

0.71

1.29

1.1

0.31

1.55

u/ml

1.54

(4027681) Cerebrospinal fluid IgG ratio and IgG index

327

1.31

1.28

1.3

0.56

0.63

ratio

0.52

188

(3042517) Benzodiazepines panel - Urine

2.16

1.28

1.9

3.2

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

2.16

1.28

1.2

2.6

2.98

4.41

nmol/l

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

498

1.24

1.20

1.6

1.7

—

(3008898) HLA-B27 [Presence]

277

2025

0.89

1.19

1.1

—

(3033086) Enterovirus Ab [Titer] in Serum

2.71

1.18

1.0

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.62

1.15

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.73

1.15

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.67

1.15

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

286

0.70

1.13

1.2

—

(3028300) Cannabinoids [Presence] in Urine

258

1887

0.89

1.13

2.4

1.7

—

(3024869) Neuronal Ab [Presence] in Serum

133

1.47

1.13

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.84

1.12

1.8

1.5

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.03

1.11

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.62

1.10

1.0

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.74

1.10

4.6

6.6

—

(3027008) Opiates [Presence] in Urine

258

1883

0.89

1.10

2.3

1.7

—

(3020874) Milk IgE Ab [Units/volume] in Serum

379

0.75

1.06

1.1

0.75

2.55

u/ml

1.01

118

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

327

0.73

1.06

1.4

1.2

13.27

8.91

mm/h

1.30

327

(3000764) Benzodiazepines [Presence] in Urine

257

1869

0.89

1.04

2.4

1.7

—

(46236302) HLA-C [Type] by High resolution typing

1.97

1.04

1.0

—

(40760409) HLA-A [Type] by High resolution

1.97

1.04

1.0

—

(40763590) HLA-DQ beta [Type]

1.97

1.04

1.0

—

(40760410) HLA-B [Type] by High resolution

1.97

1.04

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.97

1.04

1.3

1.2

346.90

341.30

umol/24h

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

202

1.35

1.03

1.2

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

332

0.74

1.02

1.1

1.0

0.52

1.46

u/ml

0.40

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

115

1.47

1.01

1.2

1.9

2.26

3.22

ug/l

0.85

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.72

0.99

1.0

1.1

109.71

98.42

titre

0.22

(3020650) Glucose [Presence] in Urine

198

1.35

0.99

2.7

1.6

0.15

0.04

estimate

0.53

198

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

185

1055

1.14

0.96

1.1

21.27

16.02

au/ml

0.28

282

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.48

0.92

1.0

—

(3013862) HLA-DP [Type]

1.86

0.90

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

426

0.79

0.89

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

142

0.64

0.87

1.0

19.08

42.18

iu/ml

1.94

142

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

425

1.21

0.85

1.1

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.81

0.0

1.1

—

169.82

—

(3011288) Drugs identified in Urine by Screen method Nominal

198

1149

1.12

0.81

3.8

2.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

446

1.19

0.80

1.1

256.03

307.84

mg/l

1.31

398

(3013139) Helicobacter pylori Ag [Presence] in Stool

710

4362

1.06

0.77

1.2

1.3

—

(3022725) Serotonin [Moles/volume] in Serum

2.16

0.76

1.2

1.1

923.40

1643.60

nmol/l

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

2.03

0.73

1.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

1.56

0.70

1.6

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

466

1.17

0.69

1.2

1.1

40.46

47.79

mg/l

0.66

396

(4038314) Semen analysis, post vasectomy

1.68

0.68

1.1

—

(3016879) Cocaine [Presence] in Urine

249

1762

0.92

0.68

2.4

1.8

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

412

2501

1.07

0.68

4.4

1.4

6.44

3.40

mg/l

4.57

386

1668

(40765089) Chromosome analysis panel - Blood by G-banded

110

0.65

0.67

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.46

0.66

1.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.68

0.63

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.41

0.62

1.6

1.5

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.62

0.62

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.62

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.62

0.0

1.1

—

64.50

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

239

1.22

0.60

1.2

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.53

0.60

1.1

1.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

269

1.21

0.60

1.1

340.49

213.20

ng/l

0.18

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

177

1259

0.91

0.57

4.6

3.8

35.68

41.87

u/ml

0.39

166

1218

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.69

0.57

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

299

2078

0.93

0.56

2.1

1.8

196.00

219.74

pmol/l

2.60

284

2013

(44806420) Estimation of glomerular filtration rate

105

606

1.13

0.54

2.8

2.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

384

0.84

0.53

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

103

595

1.12

0.53

1.2

8.10

6.81

mmol/l

3.63

497

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.39

0.50

1.1

0.46

0.17

u/ml

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

254

0.82

0.49

1.6

1.7

44.36

5.26

ug/l

0.42

163

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

443

0.86

0.49

1.1

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.51

0.49

1.4

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.35

0.48

1.1

111.27

84.60

ug/l

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

168

1003

1.09

0.48

1.3

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.38

0.45

1.0

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

578

1.11

0.45

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

468

1.12

0.44

4.7

5.5

28.51

85.06

u/ml

2.09

162

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.65

0.43

1.0

1.3

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.62

0.43

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2359

15583

0.98

0.41

2.8

2.9

0.72

0.74

ug/l

0.53

1635

9250

(3029396) Erythrocyte agglutination [Presence] in Blood

1.40

0.39

2.6

2.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

230

0.85

0.35

1.4

1.9

0.49

1.43

u/ml

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

643

0.92

0.32

1.5

1.4

0.22

0.28

nmol/l

1.05

453

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

154

1.18

0.31

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

319

1.12

0.31

5.9

7.1

23.80

108.08

ug/l

0.64

203

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.26

0.30

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.24

0.27

1.0

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

304

1.11

0.27

1.6

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

335

1.11

0.27

1.2

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

122

839

0.94

0.24

1.1

6.09

4.15

eliau/ml

0.36

410

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.80

0.23

1.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

1.25

0.22

1.2

1.4

—

(40768793) Breast Pathology biopsy report

250

1684

0.96

0.22

1.3

—

(3032641) Amino acids panel - Urine

0.00

0.22

0.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.27

0.22

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.81

0.21

1.0

1.4

0.05

0.79

u/ml

1.24

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

8.2

—

0.20

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.15

0.16

1.3

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

140

0.88

0.16

2.5

2.8

2.52

7.71

pmol/l

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

158

1.11

0.16

2.9

78.48

113.37

ng/l

0.61

(1001926) Buprenorphine [Presence] in Urine by Screen method

224

1412

1.03

0.15

2.3

1.8

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.80

0.15

1.0

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

470

3105

0.98

0.13

1.1

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

104

1.12

0.13

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

104

1.12

0.13

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

104

1.12

0.13

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.17

0.12

1.7

2.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

455

0.96

0.11

1.1

1.2

24.45

21.16

u/ml

—

175

(3010937) Rubella virus Ab [Presence] in Serum

1.12

0.10

1.0

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

113

1.09

0.09

1.1

6.34

8.41

mg/g

1.17

105

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.81

0.08

1.0

1.1

—

(40758292) HTLV I+II Ab panel - Serum

164

1.07

0.08

1.3

1.5

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

172

1.06

0.06

1.1

8.57

8.19

u/ml

0.03

112

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

448

1.03

0.06

1.0

1.1

10.96

8.68

iu/ml

0.29

131

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

191

0.95

0.05

1.9

1.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

171

0.95

0.05

1.8

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

328

1.03

0.04

1.1

1.13

1.24

u/l

0.36

168

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

123

1.06

0.04

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

201

1.03

0.03

1.2

1.4

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.94

0.02

1.7

1.1

8.71

5.68

mmol/l

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.06

0.02

1.9

2.1

—

(4133840) Spirometry

203

1.02

0.01

1.3

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.98

0.00

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

409

1.00

0.00

1.1

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

224

0.99

0.00

3.6

3.9

9.60

8.53

mg/l

0.33

183

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

200

1.01

0.00

2.8

3.0

60.79

152.89

au/ml

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.02

0.00

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

437

1.00

0.00

6.5

6.9

371.92

377.07

u/ml

0.00

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.98

0.00

3.3

2.4

—

(3029847) von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.7

—

68.17

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.0

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.94

-0.00

1.8

2.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_HEARTFAIL_AND_ANTIHYPERT and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_HEARTFAIL_AND_ANTIHYPERT	1.736 [1.61, 1.87]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.027

During the follow-up period (1.1.1998 — 31.12.2019), 86852 out of 140848 females with I9_HEARTFAIL_AND_ANTIHYPERT died.

Males

Parameter	HR [95% CI]	p-value
I9_HEARTFAIL_AND_ANTIHYPERT	2.193 [2.01, 2.39]	< 0.001
Birth year	0.985 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 75839 out of 127018 males with I9_HEARTFAIL_AND_ANTIHYPERT died.

Mortality risk

Mortality risk for people of age

years, who have I9_HEARTFAIL_AND_ANTIHYPERT.

N-year risk	Females	Males
1	0.118%	0.378%
5	0.829%	2.13%
10	2.101%	5.094%
15	3.707%	9.263%
20	6.318%	14.907%

Relationships between endpoints

↥

Index endpoint: I9_HEARTFAIL_AND_ANTIHYPERT – Heart failure and antihypertensive medication

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Heart failure and antihypertensive medication

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints